Access to person-centered care: a perspective on status,  barriers, opportunities and challenges from the Eastern  Mediterranean Region by Qidwai, Waris et al.
MIDDLE EAST JOURNAL OF FAMILY MEDICINE  •  VOLUME 7 , ISSUE 10 
            19                 
  18  
  
ISSN 1839-0188 July 2012   -    Volume 10,  Issue  6
 
Access to Person-Centered Care: 
A Perspective on Status, Barriers, 
Opportunities and Challenges from 
the Eastern Mediterranean Region
- page 4
MIDDLE EAST JOURNAL OF FAMILY MEDICINE  •  VOLUME 7 , ISSUE 10
This issue of the journal is rich 
with papers from the region and 
international. A remarkable paper 
from the International Primary Care 
Research Network dealt with ACCESS 
TO PERSON-CENTERED CARE. 
The authors attempted to look at the 
status, barriers, opportunities and 
challenges from Eastern Mediterranean 
Region. It was found that access to 
Person-Centered care in the Eastern 
Mediterranean Region shows extreme 
variations. At one end there are oil and 
gas rich countries that offer advanced 
health care services to the majority of 
their local population while on the other 
end are impoverished countries that are 
unable to provide even minimum required 
services to their people. The authors 
concluded that a well planned and 
evidence based approach is the only way 
forward to ensure universal access to all 
populations in the Eastern Mediterranean 
Region. Access to Person-Centered 
care is the need of the hour in the 
region. Provision of health care services 
through a well defined health system 
with a prime focus on a primary care 
model delivered by trained family doctors 
is the single most appropriate step to 
achieve health for all. A paper from Saudi 
Arabia attempted to identify the causes 
of stigma associated with psychiatric 
diseases and methods of its alleviation. 
Sixteen focus groups were conducted 
in half of the primary health care (PHC) 
centers of Khobar. Useful opinions were 
given, which might help in alleviation 
of stigma. The authors concluded that 
reducing the stigmatization of mental 
illness continues to be an important goal 
for mental health professionals in our 
community.
A quasi-experimental study from Iran 
assessed the impact of a computer 
learning program on asthmatic 
patients’ quality of life. Sixty patients 
were recruited to the study. In the 
intervention group, quality of life was 
significantly improved in physical 
(P=0.003), psychological (P=0.033), and 
general health (P=0.000) dimensions 
while comparing post-test to pre-test 
results; but there was no improvements 
in economic aspects (P=0.202). The 
authors concluded that a computer 
learning approach can be a useful 
method in promoting quality of life in 
patients suffering from asthma.
From the Editor
FROM THE EDITOR
A paper from KSA looked at the 
Hemorheological properties of blood 
among Saudi male Smokers. A total 
of three hundred and twenty one male 
subjects were involved. The percentage 
of cigarette smokers is high compared 
to ex and never smoked persons. The 
authors concluded that alterations of 
blood rheology in turn can promote 
atherothrombogenesis in several ways. 
Smoking increases the risk of vascular 
diseases through its effects on blood 
rheology. Further prospective and public 
health studies would be required to deal 
with common reasons which influence 
smoking behavior as well as to deal with 
the blood rheological changes.
A paper from Jordan looked at Hepatitis-
B Virus Seropositivity Among Adults 
Attending a Primary Care Clinic. A total 
of three hundred patients were involved. 
HBs Ag was positive in10 patients (3.3%) 
who came from low socioeconomic 
class. It is concluded that the HBV 
seropositivity rate (3.3%) among adults 
attending primary care clinic is low in 
comparison to the average previously 
recorded rate (10%) in Jordan. 
Screening test is not necessary, but a 
hepatitis B vaccine program and health 
education should be considered.
A Prospective study from Iraq looked at 
impaired glucose tolerance test among B 
thalassemia patients in Hawler province/
IRAQ. The prevalence of impaired 
glucose tolerance was 26% and there 
was no diabetes mellitus. The authors 
concluded that frequently transfused 
patients with under or poor compliance 
with iron chelation therapy increase the 
risk of development of complications 
including impaired glucose tolerance, 
early starting of desferrioxamine therapy 
will prevent such complications.
A paper from Iraq looked at tissue 
and plasma concentrations of 
meropenem in diabetic foot infected 
patients. Meropenem attained high 
concentrations in foot tissues in excess 
of the MICs of the isolated bacteria and 
the mean T>MIC% was 77.5± 19.45. The 
authors concluded that the the present 
data shows good tissue penetration of 
meropenem in foot tissues that permits 
its recommendation for the treatment of 
foot infections in diabetic patients.
A cross-sectional family-based study 
from Egypt was conducted aiming 
at assessing prevalence and pattern 
of Complementary and Alternative 
Practices (CAM) in the Bedouin 
Community. A considerable proportion 
(38%) of the studied population had used 
CAM at some time in the past in their 
life. The authors concluded that there 
is a considerable prevalence of CAM 
practices among the studied population 
in Bir El Abd, North Sinai. The results 
of the present study call for including 
CAM in the under and post graduate 
curriculum in medical schools, and 
continuous medical education programs. 
Training of the primary health care 
team could help in modifying behavior 
of the population in the catchment area 
towards proper use of CAM practices. 
Family physicians have a crucial role 
in doing such a task with patients and 
families. 
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Abstract  
 
Background: “Access to  
Person-Centered care” is a major 
area of concern throughout the 
world including the Eastern  
Mediterranean Region. 
Objective: This networking paper 
reviews current status, barriers, 
opportunities, challenges and 
future directions with regards 
to “Access to Person-Centered 
care” in the Eastern Mediterranean 
Region.
Methods: The lead Author from 
the “Working Party on Research 
of Eastern Mediterranean Region” 
invited members through its “ya-
hoo group” to participate in this 
networking project. Objectives and 
work plan were developed by the 
lead Author and shared with in-
terested contributors. Co-Authors 
and Advisors were invited to con-
tribute and timelines were set for 
contributors to submit their report. 
Submissions were collected by 
lead authors and put into a draft 
that was shared with contributors 
for feedback. After incorporating 
feedback, the final draft was edited 
by the “Editor” before submission 
for publication consideration.
Results: Access to Person-Cen-
tered care in the Eastern Mediter-
ranean Region shows extreme 
variations. At one end there are oil 
and gas rich countries that offer 
advanced health care services to 
the majority of their local popula-
tion while on the other end are 
impoverished countries that are 
unable to provide even minimum 
required services to their people. 
Inequalities in health status have 
been growing since the mid-1990s 
and have resulted in an increasing 
gap between the most advantaged 
and disadvantaged social groups. 
Access to Person-Centered Care: A Perspective on Status, 
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There are social, cultural,  
religious and economical  
barriers that may impede access 
to healthcare. It warrants a need 
to address these barriers on a 
priority basis so that “Universal 
access” to “Person-Centered 
care” may be made available to 
the population of the region.
Conclusion: A well planned and 
evidence based approach is the 
only way forward to ensure  
universal access to all  
populations in the Eastern  
Mediterranean Region. Access 
to Person-Centered care is the 
need of the hour in the region. 
Provision of health care services 
through a well defined health 
system with a prime focus on 
a primary care model delivered 
by trained family doctors is the 
single most appropriate step to 
achieve health for all.
Key words: Access: Primary 
Health Care, Eastern  
Mediterranean Region,  
Person-Centered care, Family 
Doctor
Introduction 
Access to health and health care 
services is based on the need, 
provision and utilization of health 
services (1) and refers to the 
ability to access health care or the 
ease of obtaining health care(2). 
It involves the entry of a given 
individual or population group into 
the health care delivery system. 
Ensuring access is not restricted to 
providing appropriate health care 
resources but extends to include its 
distribution to the most deprived, 
with justice, irrespective of social 
class or standing. The concept of 
access is multidimensional and 
includes availability, accessibility, 
accommodation, affordability, and 
acceptability as the key components 
(1). 
 
The Eastern Mediterranean region 
(EMR) is the vast area stretching 
from Morocco in the west to Pakistan 
in the east. Health indicators vary 
across the region but many are a 
cause for concern, such as life 
expectancy of 50 years in Somalia 
compared to 81.5 years in Lebanon. 
Similarly, infant mortality rate is 134 
per 1000 live births in Afghanistan, in 
comparison to 7.0 in Qatar. Disparity 
in access to and utilization of health 
and social services coupled with 
uneven distribution of resources are 
considered the main reasons for poor 
health status in the region (3).
A need was identified to look at the 
current status, barriers, opportunities, 
challenges and way forward with 
regards to “Person-Centered care” in 
the Eastern Mediterranean region. 
 
Methods 
The Lead author from the “Working 
Party on Research of Eastern 
Mediterranean Region” developed 
the idea and invited members 
through its “yahoo group” to 
participate in this networking 
project. Objectives and work plan 
were developed by the lead Author 
and shared with the interested 
contributors. Co-Authors and 
Advisors were invited to contribute 
and timelines were set for 
contributors to submit their report. 
Submissions were collected by Lead 
and Co-Authors and put into a draft 
that was shared with contributors 
for feedback. After incorporating 
feedback, the final draft was edited 
by the “Editor” before submission for 
publication consideration. Advisors, 
who were selected based on their 
experience with the subject, provided 
guidance. This paper is an evidence 
based systematic review of literature 
on access to health care and its 
utilization, issues and challenges 
in EMR. Contributors, Authors and 
Editor referred to Medline and 
Pub Med search engines, World 
Health Organization (WHO) and 
National Health Survey reports. 
Recommendations are drawn relating 
to the health services utilization 
patterns observed in EMR countries. 
 
Health care status in EMR 
region
Health care has undergone major 
transformations with an increased 
emphasis on ‘Person centred 
health care’, defined as health 
care that establishes a partnership 
among physicians, their patients’ 
and families in an appropriate and 
holistic manner with a guarantee 
that the decisions made respect the 
wants, needs and preferences of the 
patients (4,5). It ensures that patients 
are treated as equal partners and 
receive appropriate and well-timed 
care in order to meet their needs as 
individuals, regardless of any health 
and social services boundaries(6). 
The shift from “Patient-Centred” to 
“Person-Centred” signifies a shift that 
looks at patients as healthy persons 
before they get sick and try to keep 
them in good health. The overall 
quality and equitable provision of 
health care services depends upon 
the efficiency of its primary health 
care delivery and is considered the 
most appropriate way to provide 
health care in a cost effective manner 
(7). Over the past decades, EMR 
countries have realised the need 
to incorporate primary health care 
in health care delivery to improve 
access to health care (8). “Family 
Practice” is recognized as a specialty 
and is considered to be a core 
component for success of any health 
system(9). Family Physicians are and 
should be considered the main force 
that delivers primary health care.
The public sector plays a crucial part 
in delivering health care through 
strengthening health systems and 
generation of human, financial and 
other resources. Government is the 
main health provider in most of the 
EMR countries. The allocation of 
budget for the health care sector in 
the majority of these countries is very 
low, not sufficient to fulfill the health 
needs of the country’s population 
(1). This is in contrast to oil and gas 
rich countries where the situation 
is slightly better and government 
is investing substantial finances to 
improve health care services for 
their people however it is still not 
sufficient to meet the health needs of 
countries. 
 
Disease burden in the EMR 
The EMR suffers from double 
disease burden comprising 
communicable, and non-
communicable disease with 
increasing prevalence of mental 
disorders and accidents. Social and 
economical progress in EMR has 
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WHO health statistic Report 2011 
Table 1: Health indicators in Eastern Mediterranean Region
shown some improvement in health 
indicators in the region mainly due 
to social and economic development 
but these changes are slow, not 
uniform and have deteriorated in 
some countries probably because 
of poor focus on development of 
health care services10. Variations 
between and within countries are 
still very high. Maternal mortality in 
Somalia and Afghanistan is among 
the highest in the world making it a 
challenge to achieve the target of 
a two-thirds reduction in the 1990 
mortality levels by the year 2015(10). 
(Table 1 - above) 
 
Non-communicable diseases (NCD) 
are on the rise (11, 12) and deaths 
secondary to them are projected to 
increase by 15% globally between 
2010 and 2020. The greatest 
increase of over 20 % is predicted 
to be in the WHO regions of Africa, 
South-East Asia and the Eastern 
Mediterranean region (13). 
 
Family Physicians in the EMR 
There has been an increase in the 
number of physicians in almost all 
countries of EMR with the exception 
of Somalia (13). 
 
(See Table 2, page 10). 
 
This increase is not uniform and is 
greater in the oil rich countries of 
the region, with a significant number 
of physicians being immigrants 
of variable professional quality. 
Despite its established importance, 
comprehensive primary care is 
lacking in EMR countries. The 
number of trained family medicine 
specialists is low in the region due to 
imbalance between training needs 
and training programs and mal-
distribution of physicians, especially 
in rural and inner city areas. 
Deficiency created by the shortage of 
primary care physicians is either filled 
up by Family Physicians recruited 
from various western countries or by 
adhoc General Practitioners working 
in the country, who are often neither 
trained nor committed to the job 
and therefore fail to provide “Person 
Centered” care (14,15, 16). 
 
The uncooperative attitude of other 
specialties, poor support from the 
private sector with an inherent 
attitude for-profit orientation, 
along with limited awareness and 
acceptance among the general 
population regarding Family 
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Table 1a: Infant mortality per 1000 births
Physicians, decreases access to 
effective delivery of health care. The 
number of nurses and midwives in 
EMR countries is static with a fall 
in numbers in some low income 
countries due to migration (10). 
 
Provision of Primary health 
care 
The provision of primary health care 
facilities in the EMR is variable and 
several countries from all income 
groups have shown a reduction in 
the number of primary health care 
facilities over the past decades (17). 
Primary health care in Oman and 
Iran:
Oman invested consistently in its 
Wilayat health system; a national 
health service based on principles 
of primary health care and is able 
to provide almost universal access 
to health care for the majority 
of its population with an overall 
improvement in health indicators18. 
Iran has been accredited as a 
pioneer in providing primary health 
care services to the community. 
The primary health care services 
in Iran rely on trained community 
health workers called behvarz, 
trained to meet the basic health-care 
needs of people living in rural areas 
and mainly designated to provide 
service to their own village. Marked 
improvement in health indicators was 
observed improving the overall health 
of the country with a prime focus on 
rural health, However, due to rapid 
epidemiological transition and in spite 
of these achievements, still there 
is a need to address challenges in 
relation to changing health needs 
and preferences from the population 
and with an emphasis on quality 
care. (19, 20). 
 
Primary health care in Pakistan:
The national programme for primary 
health care and family planning in 
Pakistan, and lady health workers 
programme, has trained female 
community health workers to 
provide basic health care to the 
rural population of the country, but 
while expedient may not in itself 
guarantee quality of service. A 
huge improvement in coverage for 
immunization, antenatal and family 
planning services in the rural areas of 
Pakistan has been seen and is being
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Table 1b: Under five mortalty per 1000
projected as an example for other 
countries, but health indicators are 
still in need of improvement(21). 
Primary health care in Egypt:
According to the UNDP (2011), the 
population of Egypt is 82 Million 
(2009); 43% live in urban areas. 
Over 90% of the population has 
access to safe water and to improved 
sanitation. 
According to the Ministry of Health 
(MOH), private health sectors include 
private clinics and hospitals, non-
governmental organization (NGO) 
polyclinics and hospitals, in addition 
to other sporadic facilities pertaining 
to different occupations. MOH is the 
major provider of preventive and 
curative health care (80,000 beds). 
Urban areas have almost all health 
sectors present, while rural areas 
have mainly MOH health facilities, 
private clinics or NGO facilities. 
Often people bypass the primary 
health care unit / center to get better 
services in outpatient clinics of public 
hospitals, or they even resort to 
private clinics. There is no referral 
system.
Health Sector Reform Project 
(1994-2009) adopted the Family 
Health Model. It developed national 
standards for quality health care 
delivery. While welcome, this is still in 
its infancy.
- 1,103 primary clinics in two pilot  
  Governorates - Alexandria and  
  Menoufia - were upgraded to  
  family clinics services. Later on they 
  expanded family clinics to 21 out of 
  27 governorates.
- Around 1,825 general (GP) and  
  specialized physicians - 64.8%  
  females - were trained as family  
  physicians. Length of training  
  however is less than 3 years. Egypt  
  needs at least 40,000 fully trained  
  family physicians with more than the 
  current 6 month training period. 
A basic health package provides 
child health, maternal health, all age 
groups health, emergency care and 
other.
 
According to the WHO, the ratio of 
physicians per 10,000 populations 
is 28.3 in Egypt, making a total of 
226,400 physicians; 85,000 of them 
ORIGINAL CONTRIBUTION AND CLINICAL INVESTIGATION
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Table 1c: Maternal mortality per 100,000
are specialized and 18,000 are 
specialists (Physician Syndicate). 
Family physicians are few. Most 
physicians work in public and, after 
working hours, in private facilities as 
the wages are too small to cover the 
basic living requirements. Many of 
the physicians and nurses work in 
other Arab countries.
In Egypt, the burden of 
communicable and non-
communicable diseases is prevailing. 
Hypertension and liver cirrhosis 
are the two most common causes 
of death. Over a quarter of the 
adult population has hypertension 
(WHO) and 10% has HCV (EDHS 
2008). Obesity and malnutrition are 
increasing in children. A quarter 
of children are undernourished. In 
adults, overweight reached 68%. 
Smoking prevalence among adult 
men is 40% while women seldom 
smoke. 
Primary health care in Somalia and 
Afghanistan:
In contrast to the situation in Egypt 
access to basic health care services 
is very poor in Somalia(10) and 
Afghanistan(10) with poor health 
indicators in comparison to other 
countries. Diseases that have largely 
been controlled in most countries in 
the world continue to cause death 
and disability in Afghanistan and 
Somalia(10). Instability in these 
countries has greatly impacted on 
the quality and availability of health 
services, leaving many without 
access to basic care. Weakened 
infrastructure, poor literacy rates, 
shortage of health providers and 
difficult access to health care 
services have all contributed to 
increased risks of mortality for 
mothers and newborns. Healthcare 
facilities in these countries are in 
urgent need of restoration.  
 
Primary Health Care in Iraq 
According to annual report of Iraqi 
MOH 2010; the following are health 
related statistics:  
1- Infant Mortality rate =24/ 1000  
    live births (Except Kurdistan region 
    of Iraq).
2- Under 5 mortality rate=28.7/ 1000  
    live births (Except Kurdistan region 
     of Iraq).
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WHO health statistic Report 2011*
Osman H. Family medicine in Arab countries. Fam Med. 2011 Jan; 43(1):37-42**
College of physician and surgeon Pakistan***
Country profile .lebanan.Web site: http://www.emro.who.int****
Country profile .somalia.Web site: http://www.emro.who.int***** 
Table 2: Healthcare work force and infrastructure in the Eastern Mediterranean Region
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3- Number of physicians = 24750,  
    7.5/10000.
4- Number of family doctors 140,  
    0.46/10000 (Except Erbil and  
    Douhok governorates). 
5- Number of nurses =46024, 14  
     /10000.
6- Number of paramedical staff =  
    54898, 16.7/ 10000.
Primary Health Care in Bahrain, 
Jordan, Yemen and Morocco 
These countries are working in 
collaboration with WHO to implement 
a health care model based on the 
principals of a primary health care 
system. 
Trends and changes related to health 
determinants including adult literacy, 
access to safe water and access to 
sanitation has shown improvement 
in the majority of counties however 
the unsteady political situation in Iraq 
has resulted in deterioration while 
Somalia also showed decreased 
access to drinking water.
The overall situation with respect to 
provision of effective person centered 
care is not very promising in the 
region. Health services still fail to 
reach out to those who need them 
most, both in the rural areas as well 
as in the rapidly expanding urban 
areas. This difference in access 
to health care eventually has far-
reaching consequences. 
Bahrain has a Primary Care system 
based on FM with 26 excellent 
clinics but without laws to make 
it compulsory (ie full registration). 
The private sector is stopping this 
development. 
 
Access Barriers to Person-
Centered care 
Weak health care infrastructure:
Weak health care infrastructure 
including human and material 
resources is an obstacle in several 
countries with rural areas and 
urban slums adversely impacted. 
Under the current circumstances, 
it is questionable that the desire to 
have a family doctor for each family 
can be achieved in the near future. 
The availability of trained Family 
Physicians with an updated medical 
knowledge is an issue of concern 
along with lack of a support team 
for primary care delivery. Quality 
assurance processes including 
proper medical record keeping are 
also required in certain areas(22). 
Additional issues are training 
standards, and subsequently, 
competencies; quality of the 
private sector; and willingness of 
governments to invest in these areas. 
 
Dysfunctional health care system:
The health care delivery system 
is dysfunctional due to a limited 
concept of health care providers in 
relation to working, implementation 
and coordination of primary, 
secondary and tertiary levels of 
health care delivery systems. Non 
availability or poor functioning 
of primary health care facilities 
compel people to utilize tertiary care 
hospital services adding to costs 
and this eventually results in limited 
access to required health care. It is 
unfortunate that health care access 
and utilization is lowest among the 
poor who are the most deprived(22) 
leading to inequitable distribution 
of health services. Health delivery 
systems are at times dysfunctional 
due to lack of a central role of the 
Family Physician in the Primary 
Health Care team.
Distance to health care facilities:
Distance to health care facilities, 
non-availability of transport, lack 
of education, cultural (23) and 
social factors also impede access. 
These barriers are particularly 
important in countries where travel 
is difficult, employment inflexible, 
and knowledge of appropriate health 
care-seeking behavior is poor. 
Location is particularly important in 
relation to provision of obstetric, and 
especially delivery services. 
Time constraint:
Time constraint can be another 
important factor as patients and their 
attendants may have to wait for long 
hours to receive treatment because 
of dysfunctional or low numbers of 
health care facilities available. This 
represents an important cost to 
individuals, particularly during peak 
periods of economic activity leading 
to lack of adherence to treatment and 
decreased satisfaction levels.
Socio-Cultural factors:
Many social and cultural factors 
may also impede access to health 
care (22). In communities where 
men and women do not mix freely, 
utilization of health services may 
be impeded. A woman may need 
to wait for a male companion to 
visit a health care facility. There are 
also inadequate numbers of female 
health care practitioners employed 
in the government sector, a fact 
which restricts female client’s access 
to health care. Cultural and family 
opinion is particularly important in 
the demand for contraceptives and 
wider family planning advice. Lack 
of awareness regarding illness and 
preventive aspects also have an 
impact on access. Language barriers 
are also another area of concern, 
particularly when doctors from a 
foreign country see patients who 
speak another language. 
Cultural and educational factors may 
obscure the recognition of illness and 
the potential benefits from a health 
care system, for instance gender 
of a health provider may inhibit 
females utilizing health services in 
case of male physicians or women 
with ailments hesitate disclosing 
their illness to the husband in fear of 
being divorced or remarriage of her 
husband (23). 
Health seeking behavior:
Health seeking behaviors, anxiety 
and previous experiences all 
contribute towards barriers 
to access for health care e.g. 
Concerns about side effects have 
formed a deterrent to the uptake 
of childhood immunization (and 
influenza vaccinations for elderly 
people) among all social groups 
(24). A further barrier to the uptake 
of preventive services among 
some disadvantaged groups is 
the existence of a more ‘fatalistic’ 
approach to health (i.e. a belief that 
one has little control or ability to 
influence events).
Religious beliefs:
Another important area of concern 
is patient’s religious beliefs about 
illness which on one hand help in 
improving health outcomes with 
increased patient satisfaction while 
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on the other side it can also act as 
a barrier to access, for instance 
a patient’s belief about accepting 
disease and its complication as 
“Gods will” or their trust in the 
power of prayer in healing disease 
limits them from visiting health 
care providers, specifically in those 
suffering from terminal illness. There 
is also a huge use of alternative 
medicine and “religious treatments” 
that either delay access or compete 
with mainstream medical care. 
Financial (socio-economic 
reasons) :
Financial factors such as income, 
employment status, and insurance 
status can greatly influence access 
and utilization of health care. People 
in low income countries of EMRO 
region are either unable to receive 
basic health care or they receive it 
with great difficulty. In this instance 
survival care, such as shelter and 
food is given more importance, 
overlooking health care. Financial 
constraints and lack of insurance 
facilities for health care results in 
people seeking emergency care for 
acute conditions only, ignoring the 
component of preventive care.
Under recognized family medicine:
There is a lack of motivation among 
health care providers, trainees and 
medical students in the field of 
family medicine because of limited 
respect among other specialties, low 
remuneration and most importantly 
limited opportunities for training. All 
these lead to a shortage of trained 
and skilled Family Physicians in 
the region. On one end we have 
issues of shortage of adequately 
trained human resources to tackle 
health care and on the other hand 
we have a growing disease burden 
consisting of communicable and 
non-communicable disease, mental 
disorders and accidents(23).  
 
Challenges and way forward to 
achieve access to care 
We face innumerable challenges in 
order to ensure access to “Person 
Centered” care for populations in 
EMR region. A rapid population 
growth in face of resource shortages 
is an enormous challenge. The 
rising quadruple disease burden 
is difficult to control. Increase in 
ageing population puts additional 
burden and absence of government 
commitment resulting in increased 
out of pocket expense is important 
in absence of health insurance 
coverage. There is a lack of literacy 
and awareness about health issues 
among populations that puts an 
additional pressure on an already 
overburdened health delivery 
system, thereby further limiting 
access. Rapid urbanization and 
lack of facilities in rural areas are 
issues of great concern. Gender 
imbalance and related issues are 
crucial if access to health facilities is 
to improve. The private sector needs 
to be controlled so that out of pocket 
expenditures are kept within reach of 
the common man. 
Government support is required for 
health system development and is 
mandatory to improve the structure 
and function of health delivery 
system with appropriate focus and 
attention on primary care. There is 
an important role for governments, 
to provide investment in health, 
engaging people in their own health, 
shifting from disease focus to 
health focus, holistic approaches, 
continuity of care, organization of 
health services, quality and patient 
safety (linked to practitioners 
competencies), laws and regulations 
and above all the six blocks of the 
health system. (27)
Health insurance should be made 
available for all on appropriate 
terms so that access is improved for 
persons with limited means.
Training and ongoing continuing 
medical education (CME) needs 
further strengthening. Training 
programs are required for Family 
Doctors while CME opportunities 
are needed for family doctors and 
practicing general practitioners(25). 
The important issue of retention of 
trained human resources is essential 
if access to person centered care 
is to be ensured. Ongoing quality 
assurance processes should be in 
place to ensure evidence based 
practice of clinical medicine that 
takes the patient’s point of view 
into account and values patient 
satisfaction as important pillars of 
health care delivery.
Research into development and 
testing of primary care models is 
necessary to bring about changes 
in health care delivery that improves 
person centered access to health 
care. Research that explores cost 
effective interventions and positive 
health outcomes are required. Issues 
such as improvement in appointment 
systems, scheduling of patients, 
strategies to reduce patient waiting 
time in clinics and record keeping 
that requires minimum time requires 
ongoing research.
Physicians in the EMR region are 
not well aware of the philosophy, 
components, and advantages of the 
person centered model of patient-
physician consultation. It is important 
to make it part of the curriculum of all 
training programs. Implementation 
of a person centered care model will 
not only ensure patient ownership 
in addressing health issues, it will 
improve adherence to treatment, 
satisfaction with the consultation 
process and it will improve access to 
health care. 
Information and communication 
technology has advanced to the 
extent that its application can be 
used to improve access to person 
centered care. It can be used for 
communication between health 
facility and patient; messages can 
be exchanged between health 
care provider and patient and this 
technology can be used for health 
education and promotion.
The concepts of religious beliefs 
are vital in Person Centered Care. 
We should not dismiss patient 
value systems and beliefs, as the 
main drivers for Person Centered 
Care are common ground, joint 
understanding and joint decisions. 
We should not dismiss alternative 
medicine / therapies, as they are 
part of the person’s belief system. 
Indeed, empirical evidence has 
shown that some alternative / 
complementary medicines are of 
benefit to some patients/conditions. 
(26) Furthermore, the Chinese have 
incorporated successfully popular/
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alternative/complementary medicine 
into ‘Western’ medicine training and 
all Chinese medicine practitioners 
are graduates of medical schools.
Conclusion 
EMR is undergoing tremendous 
change for the better in all sectors 
of human development. Health 
care delivery is most important 
to ensure progress in the region. 
Access to “Person Centered” care 
for all populations is extremely 
important. Well trained Family 
Physicians playing a major role in 
the Primary Health Care team can 
ensure access to “Person Centered” 
care to the EMR population that can 
result in better health outcomes for 
populations of the region. 
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Abstract   
Background: Hemorheology is 
the study of flow properties of 
blood and its elements (plasma 
and formed elements). Blood vis-
cosity is correlated with cerebral 
blood flow and cardiac output, 
and increased viscosity may in-
crease the risk of thrombosis or 
thromboembolic events. 
Objective: To analyze and identify 
social, behavioral, and hemor-
heological factors related to 
smoking among young males in 
the community in Al-Jouf, Saudi 
Arabia.
Methods: Three hundred and 
twenty one male subjects (smok-
ers (195), ex smokers (105) and 
never smokers (21)) with different 
age groups were enrolled into the 
study as a randomized sample. 
Social information was collected 
from all study groups. Hematocrit 
(HCT), Whole Blood Viscosity 
(WBV) and Plasma Viscosity (PV) 
were measured at room tempera-
ture. The relationships of vari-
ables with whole blood or plasma 
viscosity were analyzed by SPSS 
17.0 and Origin 6.0 statistical 
software.
 
 
Results: Percentage of cigarette 
smokers is high compared to ex 
and never smoked persons. The 
common reason for smoking was 
the influence of the family which 
can be parent imitation, fam-
ily careless, family breakdown 
or other reasons. The smoking 
leads to a rise in hematocrit and 
alters the rheological proper-
ties by increasing whole blood 
viscosity and plasma viscosity 
levels. Together these changes 
cumulate in a significant deterio-
ration of the flow properties of 
blood.
Conclusions: Alterations of blood 
rheology in turn can promote 
atherothrombogenesis in several 
ways. Smoking increases the 
risk of vascular diseases through 
its effects on blood rheology. 
Further prospective and public 
health studies would be required 
to deal with common reasons 
which influence smoking behav-
ior as well as to deal with the 
blood rheological changes.
Key words: smokers, Whole 
blood viscosity, Haematocrit, 
Plasma viscosity
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Introduction 
Hemorheology is the study of flow 
properties of blood and its elements 
(plasma and formed elements) [1]. 
Blood viscosity is the measure of 
how thin or thick the blood fluid is. 
The viscosity of blood thus depends 
on the viscosity of the plasma, in 
combination with the hematocrit 
(Ht). Blood viscosity is correlated 
with cerebral blood flow and cardiac 
output, and increased viscosity 
may increase the risk of thrombosis 
or thromboembolic events [2]. 
The study of hemorheology has 
been of great interest in the fields 
of biomedical engineering and 
medical research for many years. 
Hemorheology plays an important 
role in atherosclerosis [3]. There is 
increasing evidence indicating that 
flow properties of blood are among 
the main determinants of proper 
tissue perfusion and alterations in 
these properties play significant 
roles in disease processes [1]. A 
strong correlation has been found 
between cigarette smoking and 
atherosclerosis and cardiovascular 
disease. Various epidemiological 
studies have investigated the 
possible associations between 
blood rheology (i.e. haematological 
characteristics that could 
influence blood flow) and coronary 
heart disease rates[4,5]. This 
experimental study was to analyze 
and identify social, behavioral, and 
hemorheological factors related 
to smoking and determine the 
hemorheological properties of blood 
changes associated to cigarette 
smoking among young males in the 
community in Al-Jouf, Saudi Arabia. 
 
Materials and Methods 
Three hundred and twenty one 
male subjects (smokers (195), ex 
smokers(105) and never smokers 
(21)) with different age groups, 
were enrolled into the study as 
a randomized sample. Social 
information was collected from all 
study groups. The study groups 
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were divided into three age groups; 
ranging from 17 - 25 years, 26 
- 36 years and above 36 years 
old. Cigarette consumption was 
classified into mild, < 20 cigarettes/
day; moderate, 21 - 40 cigarettes/
day; heavy consumption, > 40 
cigarettes/day. Informed consent 
was obtained from the subjects. 
On arrival at the clinical laboratory 
in Abdelrahman Elsidarri hospital 
Aljouf, Saudi Arabia. three tubes of 
venous blood were collected from 
the subjects; one tube (2 ml) for 
Packed cell volume assessment and 
the other two tubes (2 ml and 4 ml) 
for whole blood viscosity and plasma 
viscosity assessment. K2-EDTA 
(3.6mg for 2 ml tubes and 7.2mg for 
4ml tube) Becton Dickinson vacuum 
collection tubes were used for blood 
collection. The packed cell volume 
was measured by SYSMEX SE-
9500 in the hematology laboratory 
of Abdelrahman Elsidarri hospital. 
The whole blood viscosity and 
plasma viscosity were measured by 
Ostwald viscometer PISCO BRAND 
PRECISION SCIENTIFIC GLASS 
APPARATUS, INDIA (capillary U 
tube) at room temperature in the 
hematology laboratory of the College 
of Medical Applied Sciences (Aljouf 
University). 
Statistical Analysis
Data The relationships of variables 
with whole blood or plasma viscosity 
were analyzed by SPSS 17.0 and 
Origin 6.0 statistical software. A two-
tailed p value <0.05 was considered 
statistically significant.
 
Results 
Analysis of hemorheological findings 
between smokers, ex smokers and 
never smokers was statistically 
significant (p > 0.05) increased in the 
mean whole blood viscosity, plasma 
viscosity and Packed cell volume 
levels among smokers compared 
to never smokers, Tables 1 and 2 
(above). 
 
The social variables among smokers 
and ex smokers such as cigarettes 
consumption/day, and smoking 
period/years, our results found that 
most of the smokers were smoking 
< 20 cigarettes per day (72.8%) and 
increased the smoking period during 
the recent 1 to 5 years period of 
smoking(47.0%) compared to the ex 
smokers groups, Table 3 (page 16). 
This study indicated that the common 
factors affecting the onset of smoking 
was the influence of the family 
which can be parent imitation, family 
careless, family breakdown or other 
reasons, Figure 1 (page 16). 
 
Discussion 
The study of physical properties, 
such as viscosity, may play a critical 
role in predicting possible diseases 
as well. Physical properties of 
blood directly affect blood flow, and 
sufficient blood flow is essential 
for the health of all organs. Since 
blood supplies oxygen and nutrients 
needed for living cells and removes 
the cells’ waste products, blood 
problems arise, ranging from heart 
attacks and strokes to kidney 
disease and blindness. The results 
of the present study clearly indicate 
Cigarette smoking adversely affects 
blood fluidity by increasing blood and 
plasma viscosity. Our comparative 
findings in smokers and never 
smokers are generally in agreement 
with those previously reported by 
Dintenfass, studying 125 policemen, 
 
Smoker I: Smoking < 20 cigarettes per day.
Smoker II: Smoking 21- 40 cigarettes per day
Smoking III: Smoking > 40 cigarettes per day
Table 1: Mean level of HCT, WBV and PV in smokers (type I, II and III), ex smokers and non smokers 
 
 
A two-tailed p. value <0.05 was considered statistically significant
Table 2: Correlation between HCT, WBV and PV in smokers (type I, II and III) and non smokers
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Table 3: Incidence of cigarettes consumption and smoking period among both smokers (n,195) and  
Ex-smokers (n, 21) 
 
 
Figure 1: Factors influencing the onset of Smoking among both smokers (n,195) and 
Ex-smokers (n, 21)
and who found that smokers had 
an increase in packed cell volume, 
plasma fibrinogen concentration, 
and both plasma and whole blood 
viscosities[6]. 
Alterations in blood rheology might 
influence blood flow and play a role 
in the development of atherosclerosis 
[7]. It was shown that rheologic 
properties of blood improves with 
the cessation of smoking [8]. In 
this study hemorheological findings 
were significantly higher in current 
smokers than never smokers. 
Hemorheological properties of 
blood include whole blood viscosity, 
plasma viscosity, hematocrit, RBC 
deformability and aggregation, 
and fibrinogen concentration in 
plasma. In this study, whole blood 
viscosity, plasma viscosity and 
packed cell volume were extensively 
studied. The viscosity of blood is 
a “dynamic” property. This means 
that in viscometer, the suspension 
must flow for this property to be 
measured, so the rate of flow that 
occurs as a result of a pressure 
difference depends on the sample’s 
viscosity. It is important to point out 
that, in contrast to plasma, whole 
blood is a non-Newtonian suspension 
and thus its viscosity is dependent 
on the shear rate (i.e., flow rate) at 
which it is measured. Therefore, we 
cannot speak about a single viscosity 
of blood, but rather should always 
associate this parameter with
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the corresponding shear rate that 
has been used in its measurement 
[1]. Factors that increase WBV 
include haematocrit, total plasma 
protein, erythrocyte aggregation and 
erythrocyte deformability [9, 10]. The 
present study showed that packed 
cell volume and plasma viscosity were 
increased and then subsequently 
whole blood viscosity increased. 
Hematocrit is the most important 
determinant of blood viscosity under 
bulk flow conditions (e.g., large 
diameter vessels or large geometry 
viscometers)[11]. The physiological 
meaning of hematocrit value should 
be carefully considered. On one 
hand, the hematocrit value reflects 
the oxygen carrying capacity of 
blood since higher hematocrit usually 
correlates with higher hemoglobin 
concentration and higher oxygen 
binding capacity. On the other hand, 
the hematocrit value is logarithmically 
related to blood viscosity, hence 
a determinant of flow resistance. 
Oxygen transfer to a given tissue 
is a function of both blood flow to 
that tissue and oxygen content of 
blood flowing to that tissue. Above 
this critical value of hematocrit, 
increased blood viscosity and flow 
resistance would dominate and the 
main physiological function of blood 
flow (i.e., supplying oxygen to tissues) 
would be impaired[12]. Being related 
to the physiological importance of 
an optimal hematocrit value, RBC 
production is a well-controlled 
process [13]. The main control factor 
of RBC production is the hormone 
erythropoietin, and its secretion is, 
in turn, controlled by the degree 
of tissue oxygenation [13]. Among 
the 4,000 or more toxic substances 
absorbed during smoking, carbon 
monoxide (CO) and glycoproteins 
play a particularly important role in 
the development of smoking related 
arteriosclerotic changes, and the 
severity of the changes produced 
is influenced by the cigarette dose 
and smoking duration [14]. Plasma 
Viscosity unlike suspensions of 
red cells in plasma or whole blood, 
plasma and serum are Newtonian 
fluids with their viscosity independent 
of shear rate. This means that their 
viscosity is an intrinsic property of the 
liquid itself and there is no need to 
measure plasma or serum viscosity 
at defined shear rates [11]. Changes 
in the concentration of one or more 
plasma protein fractions will result in 
a change in plasma viscosity. Plasma 
viscosity (PV) depends primarily 
on plasma protein concentration, 
indicating that PV can vary in disease 
[15]. As a result, the fluidity of the 
blood is lowered and the viscosity of 
whole blood and plasma is increased 
[16, 17]. Plasma protein levels show a 
dose dependent increase in smokers; 
following smoking cessation, levels 
decrease towards similar values in 
those who have never smoked. 
 
Conclusion 
The percentage of cigarette smokers 
is high compared to ex and never 
smoked persons in Sakaka city, 
Saudi Arabia. The common reason 
for smoking was the influence of the 
family which can be parent imitation, 
family careless, family breakdown or 
other reasons. The smoking leads 
to a rise in hematocrit and alters the 
rheological properties by increasing 
whole blood viscosity and plasma 
viscosity levels. Further prospective 
and public health studies would 
be required to deal with common 
reasons which influence smoking 
behavior as well as to deal with the 
blood rheological changes. The 
hematological and hemorheological 
changes associated with long 
standing cigarette smoking and to 
assess whether any such changes 
were reversible after smoking was 
stopped, should be established. 
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Abstract   
Background: Thalassemia is one 
of the commonest hemolytic ane-
mias. Serious complications due 
to iron over load still occur in the 
thalassemia patients and endo-
crinal complications are among 
the complications of hemosidero-
sis especially the development 
of diabetes. The aim of the study 
was to focus on the prevalence 
and risk factors for impaired 
glucose tolerance in transfusion 
dependent thalassemia patients.
Material and Methods: A prospec-
tive study of a total of 50 transfu-
sion dependant b thalassemia 
patients aged 10-15 years); com-
prising 31 males and 19 females. 
Full history and examination 
were done along with full labora-
tory investigations, serum fer-
ritin, hepatitis B and C markers. 
Oral glucose tolerance test was 
recorded from the 1st of January 
to the 31st of April 2010.
Result: The prevalence of im-
paired glucose tolerance was 
26% and there was no diabetes 
mellitus. The risk factors for ab-
normal glucose tolerance were:  
 
 
 
 
total units of blood transfusion/
year (p=0,046).
Conclusion: Frequently trans-
fused patients with under or poor 
compliance with iron chelation 
therapy increased the risk of 
development of complications 
including impaired glucose toler-
ance. Early starting of desferriox-
amine therapy will prevent such 
complications.
Key words: thalassemia,  
impaired glucose tolerance,  
diabetes mellitus
Impaired glucose tolerance test among b thalassemia 
patients in Hawler Province, Iraq 
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Introduction 
Thalassemia is a genetic disorder 
in the globin chain production. The 
homozygous state, thalassemia 
major, results in a severe anemia 
and often death before puberty. The 
heterozygous state, thalassemia 
minor is less severe and may 
be asymptomatic with little or no 
anemia (1,2). Iraq is one of the 
countries in which 6-10% of the 
population have hemoglobinopathy 
of which thalassemia is a major 
part(1,3). Depending on the 
mutation and the degree of fetal 
hemoglobin production, transfusions 
in patients with thalassemia major 
are necessary in the 2nd months 
of life or the 2nd years of life, but 
rarely later (4). A decision to initiate 
regular transfusions in patients with 
b- thalassemia may be difficult and 
should be based on the presence 
and severity of the symptoms and 
signs of anemia, including failure 
of growth and development. But, 
transfusion results in a second 
disease due to iron overload(5,6). 
The most clinical manifestations 
of iron loading do not appear 
until the second decade of life in 
patients with inadequate chelation. 
Endocrine abnormalities are among 
the common complications of 
thalassaemia (5,7,8).
Hypogonadotropic hypogonadism, 
diabetes mellitus, and 
hypothyroidism represent the 
most common endocrinopathies in 
thalassemic patients (8-9). Impaired 
glucose tolerance (IGT) is suggested 
as a replacement for terms such as 
asymptomatic diabetes, chemical 
diabetes, subclinical diabetes, 
borderline diabetes, and latent 
diabetes (1). IGT may precede type 2 
diabetes mellitus by many years (10). 
 
The pathogenetic mechanisms 
leading from siderosis to the 
development of diabetes are still 
poorly understood (11).
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Impaired glucose tolerance and 
diabetes mellitus may be the 
consequence of pancreatic ß-
cell destruction secondary to iron 
overload, chronic liver disease, viral 
infection and/or genetic factors.(7.11) 
Three mechanisms are involved : 
1) insulin deficiency, 
2) insulin resistance, and 
3) hepatic dysfunction (12,13).
Risk factors for diabetes in patients 
with ß-thalassemia major have been 
suggested to include age, increased 
amount of blood transfusion, serum 
ferritin level, compliance with iron-
chelation therapy, family history 
of diabetes, hepatitis viruses, and 
pubertal status (14-16).
 
Aim of the Study 
To study impaired glucose tolerance 
among patients with b- thalassemia 
major and risk factors for impaired 
glucose tolerance among patients 
with b- thalassemia major, and to 
evaluate the compliance of the 
patients to the chelation therapy. 
 
Patients and Methods 
A prospective study was conducted 
at January 2010 to the end of April 
2010 on 50 thalassemic patients in 
the thalassemia center in Hawler 
governorate. The diagnosis of 
thalassemia was based on clinical 
features and hematological criteria 
(peripheral blood evaluation and 
hemoglobin electrophoresis of the 
patients). Those eligible for study 
were between 10-15 years and 
were receiving frequent transfusions 
(10-15 ml packed erythrocytes per 
kg body weight or whole blood 20 
ml/kg given every 2-4 weeks). Cases 
with family history of diabetes were 
excluded from the study. Information 
regarding name, age, sex, height, 
body weight, age at the first blood 
transfusion, frequency of blood 
transfusion per year, age at the start 
of iron-chelation therapy, compliance 
with iron-chelation therapy, history 
of splenectomy) was taken. The 
compliance with desferrioxamine 
chelation therapy was assessed as 
good (>5 desferrioxamine infusions 
per week) and poor (<4 infusions per 
week) (14).
Physical examination was done: the 
height, weight, liver span and spleen 
size in non splenectomized patients 
were recorded. Serum ferritin 
was done by Automated Architect 
Machine (Abbott Company) in the 
Medical Center.
Tests for HBs Ag and HCV-Ab were 
detected by using ELISA technique.
Plasma glucose level was assessed 
by performing oral glucose tolerance 
test with estimation of fasting and 
post prandial glucose (2 hr) plasma 
glucose (by Trinder’s glucose 
oxidase told to be fasting or called by 
telephone).
Oral glucose tolerance test was 
estimated using World Health 
Organization’s definition of impaired 
glucose tolerance and diabetes. An 
oral glucose tolerance test (OGTT) 
was performed in the morning after 
an overnight fast. A (base line) blood 
sample was drawn. Glucose was 
ingested in a dose of 1.75 g/kg up 
to a maximum of 75 g, and plasma 
glucose was estimated 2 hours later. 
Impaired fasting glucose (IFG) was 
diagnosed if fasting plasma glucose 
>110 mg/dL and less than 126 mg/dL 
(6.1-7.0 mmol/L). Impaired glucose 
tolerance test was diagnosed if the 
2 hour post glucose plasma glucose 
was >140 mg/dL and less than 200 
mg/dL (7.8- 11.1 mmol/L) and fasting 
plasma glucose was <126 mg/dl (7.0 
mmol/L). Diabetes was diagnosed 
if the fasting plasma glucose was > 
126 mg/dL (7.0 mmol/L) and 2 hour 
post glucose plasma glucose >200 
mg/dL (11.1 mmol/L). (17)
Data Analysis:
Data were entered into Statistical 
Package for Social Science (SPSS) 
 
Table 1: Demographic characteristics of 50 thalassemic patients with mean and range of each characters
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program for Windows version 16 to generate the general characteristics of the study. Quantitative variables were 
summarized by finding mean ± SD. Statistical analysis Differences between patients with and without abnormal 
glucose tolerance were tested with the independent t-test, x2 test and C-test to identify the potential risk factors. A 
two-tailed P-value of 0.05 was considered to be statistically significant. 
 
Results 
(See also Table 1 - previous page) 
 
 
Table 2: Demographic characteristics of 50 thalassemic patients in NO. and % of each characters 
 
 
P-Value (significant), ** P-Value (highly significant)This Table shows Correlation of patients characteristics with 
Impaired glucose tolerance and Normal glucose tolerance and p-value of each characters.
Table 3: Patients’ characteristics and plasma glucose 
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P-Value= 0.106 which is not significant 
Table 4: Relation of age group with GT 
Table 4 shows the Distribution of Impaired glucose tolerance and Normal glucose tolerance in thalassemic patients 
with age group. 
 
 
P. value < 0.026 which is significant difference
Table 5: Relation of the age at starting desferrioxamine therapy with Impaired GT and Normal GT in 
thalassemia patients 
The age at starting desferrioxamine therapy with plasma glucose where it is shows that 87.5% of normal glucose 
tolerance patients start desferrioxamine therapy below 5 yr. but it was 12.5% among impaired glucose tolerance 
patients.
ORIGINAL CONTRIBUTION AND CLINICAL INVESTIGATION
MIDDLE EAST JOURNAL OF FAMILY MEDICINE  •  VOLUME 7 , ISSUE 10
MIDDLE EAST JOURNAL OF FAMILY MEDICINE VOLUME 10 ISSUE 6
 
P-Value= 0.05 which is not significant.
Table 6: Relation of Serum Ferritin With Impaired GT and normal GT for patients with thalassemia 
This table shows that 21.1% of patients had IGT at S. Ferritin < 5000 while 100% of them had IGT at S. Ferritin above 
1000,this mean the risk of development IGT increase with increasing S. Ferritin, but serum ferritin was not risk factor, 
p-value not significant. 
 
 
P-Value= 0.019 which is not significant. 
Table 7: Relation of Units of blood transfusion/year with Impaired GT and Normal GT for patients with 
thalassemia
Table 7 show 6.7% of patients with IGT received <12 units of blood/year,55.6% of them received 16-18 units of blood/
year, while 100% of them received > 9 units of blood/year, but it was not risk factor.
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P-Value = 0.019 which is significant
Table 8
Patient’s height centile shows: 38 patients (76%) below 3rd centile. 
 
 
Figure 1: Compliance of patients with desferrioxamine therapy
Discussion 
In this study prevalence of IGT was 
26% which is nearly similar to the 
study done by Hafez et al, in which 
prevalence was 24.1%,(18) while 
mean age of patients who had IGT 
was 13 years and with increasing 
age the possibility of development 
of impaired glucose tolerance 
increase (Table 4), but in our study 
age was not a risk factor for IGT 
which disagrees with the results of 
Najafipour (8) in which the mean 
age of those who had IGT was 18.5 
years and age was a risk factor. This 
is may be due to our range of age 
being limited to <15 year old; males 
(62%) were more than females 
(38%), similar to the result obtained 
by Torres etal16 (19), Najafipour (8) 
and the study done by Suvarna et al 
(20) in which the male percentages 
were 60%, 64% and 60% and 
females were 40%, 36% and 40% 
respectively. 
 
The mean age of first blood 
transfusion of patients with 
thalassemia was 10.5 months, which 
was much lower than the mean age 
in a study done by Jimmy et al (14) 
12 (15.1months) and Shamshirsaz et 
al (21) 17 in which the mean age was 
(15.4 months). It appears that earlier 
presentation of the disease may 
reflect the severity of the disease in 
our country. 
Patients mean requirement for 
blood transfusions was (14.2 
transfusions/year). This is similar 
to the result obtained by Hamdoon 
(22). Those who required frequent 
blood transfusions (mean of 15.5 
transfusion/year) were impaired in 
glucose tolerance in comparison to 
those who required less frequent 
blood transfusions (mean of 13.7 
transfusions/year) in whom the 
glucose tolerance was normal. This 
agrees with the result obtained by 
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Najafipour in which the number of 
blood transfusions was a risk factor 
(Table 7) (8).
Splenectomy was done in 52% 
(26 cases) of the patients and 
this is higher than the result 
obtained by Jimmy et al (14) 12 in 
which only 20.2% of cases were 
splenectomized. This may be due 
to irregular blood transfusions 
and increased extramedullary 
activity. In those who had impaired 
glucose tolerance (69.2% of cases), 
splenectomy was done and this is 
higher than the result obtained by 
Leetanaporn et al (23) in which of 
those with IGT 50% of cases had 
splenectomy done and this may be 
due to the older age group and bad 
follow up of our patients.
In this study mean age of starting 
Desferal was 5.7 years and this 
agrees with the study done by 
Shamshirsaz et al (21) in which the 
mean age was 5.1.
Patients who started desferrioxamine 
therapy earlier at a mean age of 5.3 
years had better glucose tolerance 
than those who started later at a 
mean age of 6.7 years, and of those 
who started desferrioxamine at > 10 
years of age 100% had IGT (Table 5) 
and this mean iron over load is a risk 
factor for IGT and DM. This is similar 
to a study done by Jimmy et al (14).
Hepatitis C virus was positive in 68%, 
which is similar to the result done 
by Maria et al (24) in which 57% of 
their cases were sero positive for 
hepatitis C, and in our study all cases 
were sero negative for hepatitis B 
which may be due to the national 
vaccination program.
But there is no clear association 
between IGT and Hepatitis C in our 
study which is similar to the study 
done by Perifanis et al (25) 21 and 
Mowla et al (26).
In our study the mean of liver span 
was 11.3cm and splenic size was 
4.7cm below costal margin (24 
cases) which agrees with Suvarna 
et al (16)done in India in which 
mean liver span was 12 cm but it 
disagrees with him in splenic size in 
which splenic size was 7cm below 
the costal margin. This is probably 
because most of our cases were 
splenectomized. The weight of 52% 
of patients in this study was below 
the 3rd centile. This result is higher 
than that found in a study done by 
Gomber and Dewan (27) in which 
only 31% of their cases were below 
the 3rd centile. 
Height of 76% of them were below 
the 3rd centile and this disagrees 
with study done by Yesilipek et al 
(28) in which (32.4%) were below 
the third centile for height. This 
difference may be due to irregular 
visits and unavailability of blood, 
chelation therapy, infusion pump, 
supportive therapy of complications 
of thalassemia such as calcium, 
thyroxin, growth hormone, estrogen 
and testosterone and poor 
compliance to treatment. 
Patient’s compliance regarding 
acceptance of desferrioxamine 
therapy was found to be poor in 
100% of our cases while only 51% 
had poor compliance in a study 
done by De Santics et al (29). This is 
may be due to poor education of the 
families and the patients about the 
importance of iron chelation therapy 
and unavailability of a center with 
good facilities and equipment. 
Serum Ferritin level in our study was 
high (mean value=6127ng/ml) which 
is similar to the result of a study done 
by Suvarna et al (19) 23 (mean value 
= 7627ng/ml) and mean value of 
serum ferritin in cases with IGT was 
7030 ng/ml, and this is similar to a 
study done by Leetanaporn (23) in 
which mean value of serum ferritin in 
cases with IGT was 8679 ng/ml. But 
in our study serum ferritin was not a 
risk factor which is similar to a study 
done by Najafipour in which serum 
ferritin was not a risk factor also 
(Table 6).
In our study the mean values of 
plasma glucose were 99 mg/dl for 
fasting plasma glucose and 122mg/
dl for 2 hours post prandial plasma 
glucose which is similar to the results 
of Suvarna et al (19) 23 in which the 
values of plasma glucose were 91 
mg/dl for fasting and 127mg/dl for 2 
hours post prandial plasma glucose.
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Abstract   
Background: The terms “com-
plementary” and “alternative” 
(non-conventional) are used to 
refer to a broad set of health care 
practices that are not integrated 
into its dominant health care 
system. Practicing CAM is not 
free of contradictory views and 
reactions ranging from enthusi-
asm to skepticism. Use of CAM 
remains widespread in develop-
ing countries and is increasing 
rapidly in developed countries. 
Understanding the extent and 
patterns of CAM usage in an eco-
nomically developing country like 
Egypt is important on planning 
for health at different levels. The 
family physician is an integral 
part within the health system and 
can play a fundamental role in 
rational prescribing of CAM. He/
she can modify the inappropriate 
behavior of customers towards a 
sound one regarding CAM use.
Objectives: This study was 
conducted aiming at assessing 
prevalence and pattern of CAM 
use, as well as to identify factors 
that might affect CAM use among 
family members in Bir El Abd 
district-North Sinai. 
Subjects and Methods: This is 
a cross-sectional family-based 
study that was carried out in Bir 
El Abd district, North Sinai Gov-
ernorate. Six hundred and forty 
participants were interviewed 
face to face by trained interview-
ers. The participants (either 
husband or wife representing the 
head of the family) were invited 
to participate in a structured 
interview The obtained data were 
coded, entered and processed. 
The appropriate statistical tests 
were used to identify significant 
difference. Chi square test was 
used for categorical data. Statisti-
cal significance was considered 
at p-value <0.05.
Results: A considerable propor
tion (38%) of the studied popula-
tion had used CAM at some time 
in the past in their life. Herbal/nu-
tritional therapies were the most 
frequently used (37 %) as CAM 
therapy, followed by cupping 
(36 %). Using honey as a treat-
ment was practiced by 31% of 
members of the studied families. 
Spiritual therapy as a treatment 
was used by 11% of the studied 
families. Regarding the common 
morbidity for which complemen-
tary therapies were used, it is 
evident that hypertension (21%), 
diabetes mellitus (18%), irrita-
ble bowel syndrome (13%) and 
rheumatologic musculoskeletal 
disorders (10%) represented the 
most common morbidity among 
the studied families. The main 
source of information about CAM 
was relatives (45%), followed 
by traditional healer (21 %) and 
friends and neighbors (13 %). The 
majority of the studied  
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Introduction 
Complementary and Alternative 
Medicine (CAM) encompasses all 
forms of therapies that fall outside 
the mainstream of medical practice. 
The domain of CAM is attracting 
more and more attention.(1) 
Complementary and Alternative 
Medicine (CAM) is attracting more 
and more attention within the context 
of health care provision and health 
sector reform. Practicing CAM is 
not free of contradictory views and 
reactions ranging from enthusiasm 
to skepticism. Use of CAM remains 
widespread in developing countries 
and is increasing rapidly in developed 
countries.(2) Cultural beliefs and 
practices often lead to self-care, 
home remedies or consultation 
with traditional healers, particularly 
in deprived areas away from high 
quality health care such as in rural 
and Bedouin communities.(3) 
Regarding use of CAM among Arab 
countries, it is evident in Saudi 
Arabia, forty-six percent of the 
patients in the health facilities had 
used CAM at some time in the past 
(life time use) and about 19% had 
used it in the past 12 months.(4) In 
Africa up to 80% of the population 
uses Traditional/Complementary 
Medicine. In China, CAM accounts 
for around 40% of all health care 
delivered. The percentage of the 
population in developed countries 
which have used CAM at least 
once is 48% in Australia, 70% 
in Canada, 42% in USA, 38% in 
Belgium and 75% in France.(5) In 
a study conducted in Japan 2008, 
fifty percent of the attendants in the 
health facilities were using or have 
used at least 1 CA therapy within the 
past year.(6) 
In a population-based study 
conducted in Turkey 2008, fifty-eight 
percent of the studied population 
reported that they had used a CAM 
method at least once in the previous 
12 months.(7) About sixty-eight 
percent (67.6%) used CAM in the 
past year.(1) In many parts of the 
world, expenditure on CAM is not 
only significant, but growing rapidly. 
In Australia, Canada and the United 
Kingdom, annual CAM expenditure 
is estimated at US$ 80 million, 
US$ 2400 million and US$ 2300 
million respectively. In Malaysia, 
an estimated US$ 500 million is 
spent annually on this type of health 
care.(2) Studying of medicinal 
products from natural sources is 
now being included in the curriculum 
of some pharmacy schools and 
colleges in the United States.(8) The 
increasing use of CAM has not been 
associated with an increase in the 
quantity, quality and accessibility 
of clinical evidence to support 
CAM claims despite existence of 
strong evidence from randomized 
clinical trials for many uses of CA 
practices.(2) 
 
It is evident that policy-makers, 
health professionals and the public 
in many parts of the world are 
faced with questions about the 
safety, efficacy and quality of such 
therapies. Many patients seek out 
alternative medicine after they have 
tried conventional medicine and 
found it to be ineffective or to result 
in terrible side-effects.(9) On the 
other hand; practicing of CAM may 
result in problems of compliance 
with conventional therapy and 
may expose patients to hazards of 
traditional remedies that have not 
been scientifically tested.(10,11,12) 
There is strong recommendation 
issued by WHO towards rational use 
of CAM through integration of CAM 
into national health care systems 
and developing national policies on 
CAM, of the member states.(2) In 
spite of its importance, little is known 
about the overall prevalence, pattern 
of CAM use among the Egyptian 
population. Doctors’ understanding 
of the pattern of CAM use, the 
characteristics of users and patients’ 
perception is important for conducting 
successful consultation and effective 
care to the practice population. 
However, there is very little research 
that describes CAM use in Egypt. 
This study aimed at identifying 
prevalence and pattern of CAM use 
among family members in Bir El Abd 
district-North Sinai, Egypt as well as 
to identify factors that might affect 
CAM use.
population (91 %) perceived 
CAM as beneficial. Concerning 
the relation of CAM use and 
some socio-demographic 
factors, it was evident that, 
use of CAM showed significant 
association with age and 
education (P<0.05). CAM did not 
show significant association 
with gender, employment 
status, marital status, monthly 
income or coverage with health 
insurance using uni-variant 
analysis (P>0.05).
Conclusion and 
recommendation: There is a 
considerable prevalence of CAM 
practices among the studied 
population in Bir ElAbd-North 
Sinai. The results of the present 
study call for including CAM in 
the under and post graduate 
curriculum in medical schools, 
and continuous medical 
education programs. Training of 
primary health care teams could 
help in modifying behavior of 
the population in the catchment 
area towards proper use of CAM 
practices. The family physician 
has a crucial role in doing such 
a task with patients and families. 
Key words: Complementary 
Medicine, Alternative Medicine
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Subjects and Methods 
This cross-sectional family-based 
study was conducted in two villages 
(Elnasr and Nagella) representing 
a rural community belonging to 
Bir El Abd District, North Sinai 
Governorate. The estimated 
population of Bir El Abd was 72,678 
for the year 2010. The population 
in this community is cared for by 16 
primary health care units belonging to 
the Ministry of Health and Population 
(MOHP) and the other one is the 
Family Practice Center affiliated to 
the Faculty of Medicine Suez Canal 
University (FOM/SCU). 
The sampling unit used in the study 
was the family. This was defined 
as a group of individuals living 
together in a household, and usually 
included the father, the mother, 
sons and daughters and sometimes 
grandparents. A structured 
questionnaire was designed to fulfill 
the study objectives. It consisted of 
two sections. The first section was 
concerned with the personal and 
socio-demographic characteristics of 
the participants (age, gender,) and 
education, income of the family and 
health insurance of the respondent. 
The second section enquired about 
CAM use at any time.
Testing feasibility and reliability 
of the questionnaire was done 
by conducting a pilot study on 20 
volunteers. Consent was obtained 
from the participants to participate 
in the study and answer the 
questionnaire, after sharing with them 
the objectives of the study. Also, 
confidentiality of data was ensured. 
The participants (either husband or 
wife representing the head of the 
family) were invited to a structured 
interview with the trained interviewers 
under supervision of the researcher.
The obtained data were coded, 
entered and processed on a 
personal computer using Statistical 
Package of Social Science (SPSS). 
The appropriate statistical tests 
were used to identify significant 
difference. Chi square test was used 
for categorical data and Fischer 
Exact test was used if at least one 
expected value was less than 5. Also, 
logistic regression test was used. A 
stepwise logistic analysis was used 
to test association of CAM use with 
the studied variables. Statistical 
significance was considered at p-
value <0.05. 
 
Results 
In the current study, the total sample 
of 640 families were represented 
by either the head of the family 
(husband) or the housewife, of whom 
305 were males (47.7%), and 335 
were females (52.3 %). Seventy 
three percent of the respondents 
were married currently. More than 
one-third of the studied population 
(37 %) was either illiterate or could 
read and write at primary level. 
About three-quarters (77%) of the 
studied population were unemployed. 
Seventy percent of them have 
perceived their monthly income as 
inadequate for their families and 23 
% were insured by the health system. 
A considerable proportion (38%) 
of the studied population had used 
CAM at some time in the past in their 
life. Herbal/nutritional therapies were 
the most frequently used (37 %) as 
CAM therapy, followed by cupping 
(36 %). Using honey as a treatment 
was practiced by 31% of members of 
the studied families. Spiritual therapy 
as a treatment was used by 11% of 
the studied families. Spiritual therapy 
including praying and treatment by 
Holy Qur’an (either by self-reciting 
the Qur’an or having the Qur’an 
recited over water which was then 
drunk or massaged). Bee sting and 
acupuncture were used by 7% and 
2% respectively.
Regarding the common morbidities 
for which complementary therapies 
were used, it is evident that 
hypertension (21%), diabetes 
mellitus (18%), irritable bowel 
syndrome (13%) and rheumatologic 
musculoskeletal disorders (10%) 
represented the most common 
morbidity among the studied families. 
On the other hand bronchial asthma 
(5%), chronic liver disease (4%), 
impotence (2%), rheumatoid arthritis 
(1%) and peptic ulcer diseases (1%) 
came at the bottom of the list. 
The main source of information about 
CAM was relatives (45%), followed 
by traditional healer (21 %) and 
friends and neighbors (13 %). On the 
other hand, physicians constituted 
only 9 % as source of information 
for using CAM. The majority of the 
studied population (91 %) perceived 
CAM as beneficial and the lower 
proportion perceived it as not 
beneficial (9 %). 
 
Concerning the relation of CAM 
use and some socio-demographic 
factors, it was evident that, CAM was 
used more frequently among males 
(51.4 %) than females without a 
statistical difference (P>0.05). Use of 
CAM showed significant association 
with age (being more users (89%) if 
age < 60 years), being more users 
if illiterate (29%) and read / write/
completed only primary education 
(32.7%)(P< 0.05). On the other 
hand, CAM did not show significant 
association with marital status, 
monthly employment status, income 
and coverage with health insurance 
(P>0.05). 
After adjustment using stepwise 
logistic regression analysis, the 
expected probability of CAM use 
among the studied population 
decreased by 0.5 if illiterate/read 
/write or completed primary or middle 
level of education (P<0.05). Also, it 
decreased by 0.68 if unemployed 
(P<0.05). Age, gender and monthly 
income as studied variables showed 
no effect on using CAM after 
adjustment using stepwise model 
when other variables are constant. 
 
Discussion 
The current study was conducted 
on 640 families in North Sinai, 
Egypt. It was aiming at identifying 
the prevalence and pattern of CAM 
use among the studied families As 
well as to identify factors that might 
influence use of CAM. In the current 
study, more than one-third (38%) of 
the studied families have used some 
forms of CAM at some time in the 
past for their family members. These 
results were in agreement with the 
obtained results from Belgium(42%) 
and China (40%).(2,13) Also, they 
were consistent with the reported 
results from two separate studies in 
USA (34 %) and (49%).(14,15) The 
use of CAM ranged, and ranged 
between forty-fifty percent,(6,16-18) 
in other countries such as Japan, 
Australia and European countries. 
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Table 1: Socio-demographic characteristics of the studied families 
 
 
Table 2: Distribution of the studied population according to the use of CAM among family members
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Table 3: Types of CAM practices 
among family members of the 
studied families
Table 5: Use of CAM 
therapies among family 
members of the studied 
families according to source 
of information
Table 4: Use of CAM 
therapies among family 
members according 
of the studied families 
according to the type of 
morbidity
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Table 7: Relation of using of CAM and some socio-demographic characteristics among the studied families 
Table 6: Distribution of the 
studied families according to their 
perception towards benefit of CAM 
practices
*Statistically 
significant 
Table 8: Stepwise 
logistic regression 
analysis for CAM 
use among family 
members and 
studied variables
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On the other hand, the results from 
the current study were lower than 
those reported from Africa and 
Canada. It is evident that up to 80% 
and 70% of the studied population 
have used CAM respectively.(2,13) 
A contradictory view was reported 
from population-based studies in 
USA and Australia which showed 
results ranging from 66%-68% by the 
year of 2002.(1,19) The situation in 
the Eastern Mediterranean Region 
was no exception where results of 
a household study showed 73% 
and 56% of the studied population 
have used CAM in Saudi Arabia and 
Turkey respectively.(4,7) The use of 
CAM as a treatment modality among 
those attending health facilities, 
was less. In a study conducted in 
health facilities in Saudi Arabia, it 
was found that nineteen percent 
used some form of CAM practices 
in the past.(20) In one of the earliest 
countries that paid more attention to 
CAM at the level of education and 
practice: reports from West Germany 
showed that, CAM was used by only 
six-percent of the studied population 
which was considered to be a low 
prevalence.(21)
The above mentioned studies 
showed moderate-high use of CAM 
in both developed and developing 
countries comparable to the midway 
results obtained from the current 
study. The relatively high use of 
CAM might be explained in the 
background of an existing trans-
cultural view towards use of CAM 
practices before seeking medical 
advice from the medical profession 
or even after. Also, patients in rural 
areas experience a variety of unmet 
needs partly due to fewer resources 
to choose from, poverty, perceived 
reliability of these therapies based 
on folklore or family traditions and 
the availability of such practices. 
All of these factors may contribute 
to the use of CAM therapies. 
Also, physicians’ attitudes towards 
CAM and poor patient-doctor 
communication may be other 
reasons why patients use CAM 
more and even without informing the 
treating physician.
The most frequently used types 
of CAM in the current study were 
the herbal/dietary therapies (37%), 
cupping (36%), honey (31%), 
spiritual healing (7 %) as a treatment 
was used by 11% of the studied 
families. Spiritual therapy including 
praying and treatment by Holy Qur’an 
(either by self-reciting the Qur’an or 
having the Qur’an recited over water 
which was then drunk or massaged). 
Other therapies such as bee sting 
and acupuncture were not frequent 
(7% and 2%). These results were in 
partial agreement with reports from 
Saudi Arabia(4,20) where Qur’an, 
honey and herbs particularly black 
seed came at the top of the list. 
Among western countries, the results 
showed that prayer/spiritual healing; 
herbs, relaxation, vitamins, massage, 
acupuncture and commercial 
weight loss programs were common 
CAM practices among adults and 
elders.(1,15,22-25) 
Herbal therapies are considered one 
of the most frequently used CAM 
practices. According to the World 
Health Organization (WHO), more 
than three-quarters of the world’s 
population rely upon traditional 
medicine, mainly herbs.(26) These 
results were higher than those 
reported from North Carolina: 
twenty percent of participants 
had used medicinal herbs,(27,28) 
comparable to the results brought 
from Turkey where 58.5% of the 
studied population have used herbal 
therapies.(7) Evidence-based 
medicine is acquiring more interest 
worldwide. Herbal therapies are 
no exception. Awareness of health 
care providers who are in touch with 
herbal therapy as family physicians 
is acquiring more interest as 
emphasized recently by the American 
Academy of Family Practitioners 
(AAFP)- Annual Scientific Assembly-
2006 to be evidence-based.(26,29)
It is evident in the present study 
that CAM practices were used for 
chronic morbidity. Hypertension 
(21%), diabetes mellitus (18 %), 
irritable bowel disease (13 %) and 
Rheumatologic musculoskeletal 
disorders (10%) were the common 
conditions for which CAM was used. 
On the other hand, use of CAM for 
bronchial asthma and chronic liver 
disease were uncommon. These 
findings were consistent with those 
reported from Saudi Arabia where 
CAM use was highest for headache, 
irritable bowel syndrome and back 
pain.(20) Also, in another study, 
17.4% of diabetic patients used 
herbs to treat diabetes mellitus.(30) 
The situation among Americans 
and Indians was not far from the 
obtained results, CAM was used to 
treat neck pain, joint pain or stiffness, 
back pain, diabetes mellitus, 
hypertension, arthritis and anxiety or 
depression.(31, 32)
The use of CAM therapies 
encompassed a wide spectrum 
of medical problems ranging from 
simple, transit and self limited up 
to serious, long term disabling and 
terminal problems. Such practices 
in the current study or among the 
other studies could be explained 
by the traditions, the deeply seated 
values and perception of the patient 
towards CAM. The majority of the 
studied population who used CAM 
(91 %) perceived it as a beneficial 
treatment modality. They used it 
widely in different medical problems. 
A higher figure (75%) was reported 
from Japan.(6) These results were 
in disagreement with those reported 
from Saudi Arabia, where 70% of 
patients perceived it as dangerous. 
(20) 
 
The main source of information about 
CAM was relatives (45 %), followed 
by friends (23.1%) and traditional 
healer (21%). On the other hand, 
physicians constituted only 9 % as a 
source of information for using CAM. 
These results were consistent with 
those from Turkey where the source 
of information of CAM was mainly 
the relatives, friends or neighbors.(7) 
In Saudi Arabia, relatives, neighbors 
and friends were the main source of 
information. On the other hand media 
was mentioned less frequently.(20) 
A considerable proportion of the 
patients did not inform their treating 
physician about their CAM use.(7,20) 
Reports from the USA showed 
that CAM users were more likely 
to receive CAM information from 
friends, family, the popular media 
and the Internet than from their 
physicians.(33)
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The discrepancy of the results 
obtained in the current study and the 
others might reflect the peculiarity 
of socio-demographic and cultural 
variables in each community. The 
need to make the physician a source 
of information was apparent. Also, 
being the only source of information 
is inadequate but to be evidence-
based as emphasized recently 
by American Academy of Family 
Practitioners (AAFP) is beneficial.(29) 
A good doctor-patient relationship is 
of utmost importance in this regard, 
where in the absence of such a 
relationship, the patient may deny 
such CAM rather than informing his 
physician. 
It was evident that CAM use has 
shown a significant association 
with some socio-demographic 
factors. It was used more frequently 
among males (51.4 %) compared to 
females without significant difference 
(P>0.05 %). CAM showed significant 
association with age and education 
(P<0.05). On the other hand it did 
not show a significant association 
with marital status, monthly income 
or coverage with health insurance 
(P>0.05). These results were in 
partial agreement with those reported 
from Japan and Turkey, USA where 
use of CAM was associated with 
gender (towards the female). Also, 
it was correlated to older age and 
higher education.(6,7,34) On the 
other hand, results have been 
obtained from Saudi Arabia in which 
housewives and individuals who had 
no formal education were found more 
likely to use CAM.(20) 
After adjustment using stepwise 
logistic regression analysis, the 
expected probability of CAM use 
among the studied population 
decreased by (0.5) if illiterate/read 
/write or completed primary or middle 
level of education (P<0.05). Also, it 
decreased by 0.68 if unemployed 
(P<0.05). Age, gender and monthly 
income as studied variables 
showed no effect on using CAM 
after adjustment using stepwise 
model when other variables are 
constant. These results were in 
partial agreement with the results 
from the USA and showed that: rural 
residence, age, income, education, 
and health insurance were unrelated 
to CAM use. (35) Also, in another 
study, being female will be more 
likely be a CAM user.(36) The role 
of socio-demographic variables 
are considered to be important as 
predictors of CAM use. The weight of 
such variables as predictors will vary 
from one country to another. 
 
Conclusion 
There was a considerable prevalence 
of CAM practices among the 
population in Bir El Abd, North Sinai. 
These results call for including CAM 
in the under and post-graduate 
curriculum in medical schools, 
and continuous medical education 
programs.
Training of primary health care 
teams could help in modifying 
behavior of the practice population 
towards rational use of CAM 
practices. Encouraging physicians 
to learn more about CAM products 
and treatments and to routinely 
screen all patients for CAM use is 
required. Urgent health education 
programs addressing safe and 
unsafe practices regarding CAM 
directed to the community are a pre-
requisite. The Family physician is in 
a unique position to do such a task 
with patients because they maintain 
a good doctor-patient relationship 
with the practice population. Study 
limitation and generalizability
The obtained results cannot be 
extrapolated or generalized on 
the Egyptian community because 
the study was conducted only in a 
Bedouin community that has specific 
characteristics. Further studies 
representing rural and urban areas 
are needed to give an overall view of 
CAM use in Egypt. 
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Abstract   
Objective: Meropenem is a broad 
antibacterial agent against most 
pathogens causing diabetic foot 
infections. The pharmacodynam-
ics parameter, time during which 
antibiotic concentration remains 
above the MIC for the infect-
ing pathogen (T>MIC) has been 
recommended for good efficacy. 
This study aimed to determine 
meropenem concentrations in 
plasma and foot infected tissues 
in diabetic patients and relate 
these values with microbiological 
findings.
Patients and Materials: Ten 
patients with diabetic foot infec-
tions were enrolled in the study. 
Microbiological examination and 
the minimum inhibitory concen-
tration (MIC) were determined 
for foot infected samples. All 
patients received meropenem by 
intravenous infusion of 1000 mg 
for 30 minutes at 8 hourly inter-
vals. Blood samples were taken 
after 1, 2, 4, and 8 hours of the 
last meropenem dose and  
 
 
 
the plasma meropenem concen-
tration was analyzed by HPLC. 
Viable soft tissue samples were 
obtained at time of amputation 
and meropenem concentration 
was determined by microbiologi-
cal assay.
Results: Meropenem attained 
high concentrations in foot  
tissues in excess of the MICs 
of the isolated bacteria and the 
mean T>MIC% was 77.5± 19.45. 
Conclusion: The present data 
shows good tissue penetration of 
meropenem in foot tissues that 
permits its recommendation for 
the treatment of foot infections in 
diabetic patients.
Key words: pharmacodynamics, 
meropenem, T>MIC.
Tissue and plasma concentrations of meropenem in 
diabetic foot infected patients 
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Introduction 
Pharmacodynamics of antimicrobials 
explore the relationship between the 
attained drug concentrations and the 
infecting organism with the clinical 
outcome (1, 2).
Achieving therapeutic drug 
concentrations at the site of infection 
is one of the main goals of antibiotic 
therapy especially where peripheral 
vascular circulation is embedded in 
situations such as foot infections of 
diabetic patients (2, 3).
Some antibiotics when used in 
the treatment of diabetic foot 
infections, may attain adequate 
blood levels but may not achieve 
sufficient antimicrobial concentration 
in infected tissues to combat 
the infection leading to more 
complication that may necessitate 
amputation (1, 4, 5).
Choosing antibiotics for diabetic 
foot infections should include an 
agent active against staphylococci, 
Gram-negative bacilli, Enterococcus 
and anaerobic species especially in 
previously treated or severe cases 
as they are involved in diabetic foot 
infections (6, 7, 8).
Meropenem is a broad-spectrum 
carbapenem antibiotic with excellent 
activity against many pathogens 
associated with complicated 
skin and soft tissue infections 
(cSSTIs)(9). 
 
The optimal pharmacodynamic 
parameter predicting microbiologic 
efficacy is the time that the drug 
concentration in the blood remains 
above the MIC (T> MIC) (1, 10, 11). 
Pharmacokinetic studies revealed 
that meropenem penetrates rapidly 
and widely into a range of body 
fluids and tissues (12, 13) resulting 
in sufficient T>MIC in body fluids 
enough to kill bacteria (11, 14) and a 
regimen which provides a T>MIC of 
40% of the dosing interval has 
ORIGINAL CONTRIBUTION AND CLINICAL INVESTIGATION
MIDDLE EAST JOURNAL OF FAMILY MEDICINE VOLUME 10 ISSUE 6
MIDDLE EAST JOURNAL OF FAMILY MEDICINE  •  VOLUME 7 , ISSUE 10
been recommended to be sufficient 
to produce maximum microbial killing 
(15, 16). 
The objective of this study is to 
predict the exposure of pathogens 
isolated from foot lesions of 
diabetic patients to meropenem 
to characterize the relationship 
of pharmacodynamics indices to 
microbiological response. 
 
Patients and Methods 
The enrolled patients with a mean 
age 59±6 years (6 males, 4 females) 
had diabetes mellitus type 2 with 
foot lesions of Wagner grade III and 
IV and were to undergo surgical 
amputation in the orthopedic 
department in Erbil teaching hospital. 
Written consent was taken from all 
patients and the Ethical Committee 
Approval was obtained. Exclusion 
criteria were patients with a history 
of antibacterial medication within 
two weeks before the surgery, end 
stage renal impairment and history 
of allergy to b-lactams antibacterial. 
Blood sugar, renal function tests and 
X-ray were investigated for each 
patient. Serum glucose levels were 
controlled by insulin in each of these 
subjects, by the consultant during the 
study. 
Microbiology
Sterile swabs were taken after 
debridement from the base of the 
infected ulcer for microbiological 
study. Bacterial isolation and 
identification for aerobic and 
anaerobic bacteria and the minimum 
inhibitory concentrations (MICs) 
of each bacterial isolate were 
determined using Vitek 2 compact 
diagnostic technique ( (BioMe´rieux 
Inc., Hazelwood, MO). The MIC was 
also determined by micro-dilution 
method according to the National 
Committee for Clinical Laboratory 
Standards (2003)(17). 
Drug administration
All patients received the antibiotic 
meropenem (Merrem; AstraZeneca 
Pharmaceuticals, Wilmington, DE) 
as IV infusion at the recommended 
dose of 1000 mg for 30 minutes eight 
hourly intervals. Blood samples were 
withdrawn in heparinized tubes from 
an indwelling intravenous catheter 
placed into the arm contralateral to 
the one used for the drug infusions 
after 1, 2, 4, and 8 hours of the last 
dose of meropenem administration. 
Plasma was obtained after 
centrifugation and kept at -40 ° C 
until analysis. 
Analytical Methods
The concentration of meropenem 
in plasma was analyzed by a high 
performance liquid chromatography 
(HPLC) method (18). The HPLC 
instrument used was the Knauer 
HPLC instrument (Smartline manager 
5000 with UV detector) equipped with 
ChromGate software. 
Extraction of plasma samples: 
Briefly, plasma samples (0.5 ml) were 
treated then with TCA (15%) and 
with a mixture of water: acetonitrile 
(80:20). The samples (10 µl) were 
then eluted on a reversed-phase 
column (C8) with a mobile phase 
containing Methanol: Water (80:20) 
with a flow rate of 1 ml/min and UV 
detector set at 254 nm.
Spiked plasma samples containing 
meropenem in the range of 0.1-
1000 µg/ml was prepared by adding 
aliquots of meropenem stock solution 
to blank plasma. A calibration 
curve of different concentration of 
spiked meropenem was prepared 
and accordingly the unknown 
concentration of meropenem in 
patient’s plasma was calculated. 
Tissue samples: A peri necrotic 
soft tissue sample was excised from 
the infected foot deeply at the time 
of amputation from each patient at 
times relevant to the timing of the 
blood samplings. The tissues were 
wiped gently with dry sterile gauze, 
placed in sterile pre-weighed vials 
and stored at (-40 ºC) until time 
of analysis by a microbiological 
method according to the method of 
Byl et al (19). The tissue samples 
were thawed to room temperature, 
sliced into small pieces (2-3 mm) 
with sterile surgical scalpel, weighed 
and placed into a sterile test tube 
to which phosphate buffer (pH 6.8) 
was added (1:1), and vortexed for 10 
minutes. The supernatant was taken 
and treated with 0.5 ml of acetonitrile: 
water (1:1), vortexed, centrifuged 
at 3000 rpm for 30 minutes and the 
supernatant was taken for analysis 
by microbiological assay method.
Muller Hinton agar medium was 
prepared and inoculated with fresh 
bacterial suspension (0.05 ml) 
of standard E. coli ATCC 25922. 
Hundred microliters of each extracted 
sample was placed into holes 
(4mm) made in each Petri-dish. 
Different concentrations of standard 
meropenem were prepared and 
extracted by the same procedure 
mentioned above and analyzed 
with the patients’ samples for 
meropenem. For each unknown 
sample three Petri-dishes were used 
with a standard sample. The plates 
were then incubated for 18 hours at 
37°c, after which the diameter of the 
zones of inhibition were read and 
then the concentrations of unknown 
meropenem in different samples were 
calculated. 
 
Calculations of pharmacokinetic 
parameters (half-life(t1/2 ), apparent 
volume of distribution; Vd, Clearance 
(Cl), and the percent of dosing 
interval for which concentration 
exceeding the MIC (T>MIC% ) 
was calculated according to the 
mathematical equation given by 
Burton et al (20). The area under 
plasma concentration curve (AUC) 
was calculated by the trapezoidal rule 
method. 
 
Results 
The swabs obtained from the 
ten patients before meropenem 
administration revealed the presence 
of 13 different bacterial species 
such as Klebsiella pneumonia, 
Escherichia coli, pantoea 
agglomerans, Pseudomonas 
aeroginosa, Staphylococcus aureus, 
Morganella morgani, Enterrococcus 
faecalis, Enterrococcus raffinosus, 
Leuconostic lactis, Citrobacter 
freundi, Proteus vulgarisas, Kocurea 
rosea and Yersinia enterrocolotica 
(Table 1 - next page). 
 
In vitro antibacterial susceptibility 
test showed that all isolated bacterial 
strains were sensitive to meropenem. 
The MIC values of meropenem for 
the isolated bacteria ranged from 
0.06 - 3.9 ± 0.9 µg/ml (Table 1).
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Table 1: Microbiological findings, the minimum inhibitory concentrations (MIC) and the percent of dosing 
interval for which meropenem concentration exceeds the MIC (%T>MIC) of different pathogens isolated from 
the diabetic foot infected patients
 
Figure 1: The mean plasma concentration curve of meropenem in ten patients after intravenous infusion of 
meropenem at 1000 mg over 30 minutes every eight hours
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The mean plasma concentration 
of meropenem declined from 
72.87±12.02 to 0.42±0.31 µg/ml after 
1 and 8 hours of administration of the 
last dose following first-order kinetics 
(Figure 1). Tissue concentrations 
were highly comparable after IV 
infusion of meropenem with the 
highest concentration 32.00±11.03µg/
g obtained 2 hours after the last 
administered dose (Table 2). The 
pharmacokinetic parameters for 
meropenem in plasma (Table 3) 
showed that the mean plasma t ½ 
, volume of distribution (Vd), total 
clearance and the area under the 
plasma curve (AUC) of meropenem 
in these patients were 0.91±0.1h, 
31.41±7.44 (L/Kg), 23.8±6 (L/h) and 
156.27±39 (mg. h /l) respectively. 
 
The percent of T>MIC for the 
isolated bacteria from each patient 
ranged from 29.7 to 98.1% (Mean 
77.5±19.45%); with the lowest 
percent for Enterococcus faecalis 
while the highest value was for the 
Kocurea rosea (Table 1). 
 
Discussion 
The most important criterion of 
antimicrobial activity is the actual 
tissue concentration at the site of 
infection (1, 11).
The high concentrations of 
meropenem achieved in foot tissues 
of the diabetic patients shown in this 
study, exhibits its good penetration. 
Numerous studies have shown that 
meropenem penetration to different 
organs provides adequate tissue 
concentrations for the treatment 
of various infections caused by 
susceptible bacteria (19, 21, 22, 
23, 24, 25). Sustained meropenem 
levels higher than the MIC90 were 
observed in the colon, gall bladder, 
fascia, muscle, omentum, and skin 
(11, 26, 27, 28). 
Meropenem exhibited an adequate 
spectrum of in vitro activity against 
all the bacterial isolates from the 
diabetic patients which coincide with 
those reported by numerous authors 
(29, 30, 31). 
Although anaerobes may accompany 
skin and soft tissue infections (2, 
9) however in these patients, no 
anaerobic bacterium was isolated. 
The MIC values obtained for the 
isolated bacteria indicates that 
they were sensitive since their MIC 
values were close to those published 
for sensitive bacteria by many 
authors (32, 33,34,35) . Although 
different species of enterococci are 
shown to have higher MICs than 
enterobacteriace, nevertheless it was 
also close to those meropenem MIC 
values reported for this bacteria (36) 
Meropenem is considered to exhibit 
time-dependent killing activity (37, 
38) , this means that the antibacterial 
efficacy necessitates concentrations 
to be maintained at a certain minimal 
level for sufficient period of time. 
Indeed the levels of meropenem 
in the foot tissues in this study 
were above MIC90 for susceptible 
bacteria (4µg/ml) isolated from the 
patients and since that T> MIC of 
20%- 40% is a good prognostic 
indicator for successful bacteriostatic 
and bactericidal responses of 
carbapenems(11,40) so the range of 
T> MIC (29.7-98 %) determined for 
meropenem indicates its effective 
antibacterial activity in diabetic foot 
infected patients. 
 
Suggesting effective dosing regimen 
for time-dependent antibiotics 
requires drug concentrations to 
exceed the MIC of the causative 
pathogen for at least 40% to 50% 
of the dosing interval (39, 40) 
therefore, for instance in the present 
study, klebsiella pneumonia (MIC 
0.12µg/ml) produced a T> MIC% 
of about 86.76 % which means 
that meropenem will be effective 
for a period of 6.9 hours and for 
Pseudomonas aeuroginosa (MIC 
0.06µg/ml) activity cover about 7.76 
hours for each dosing intervals 
(8 hourly) which indicates a good 
efficacy in such a clinical condition. 
However, for enteroccocus faecalis 
 
 
 
n; number of patients.
Table 2: The mean plasma 
and tissue concentrations 
of meropenem after the last 
intravenous infusion of 1000 
mg every eight hours to 
diabetic patients 
 
 
 
 
 
 
 
 
Table 3: Pharmacokinetic 
parameters of meropenem 
in ten diabetic patients after 
intravenous infusion of 
meropenem at 1000 mg over 30 
minutes every eight hours
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and enterococcus raffinosus with 
a T> MIC% of 29.7% and 38.14% 
respectively and considering less 
than 40% of the dosing intervals 
for good efficacy, meropenem 
will remain effective only for less 
than 3.2 hours, therefore requires 
optimizing dosing strategies to 
maximize the duration of drug 
exposure as administering the drug 
at longer intravenous infusions or by 
continuous intravenous infusion (41, 
42).
However, since these agents show 
some degree of post antibiotic effect 
(PAE) in spite of short duration (43, 
44, 45, 46), then this persistent 
effect would allow a longer effective 
dosing interval. Indeed, twice-daily 
administration of meropenem has 
been shown to be as effective as 3-
times daily administration in patients 
with bacterial infections. (11, 47, 48) 
In conclusion, this study has shown 
that meropenem reaches sufficient 
concentrations in infected wound 
tissue of diabetic foot tissues and 
with debridement might cover an 
adequate spectrum well suited for the 
treatment of skin structure infections 
of diabetics, caused by susceptible 
organisms.
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Abstract    
Objective: The aim of this study 
was to estimate the hepatitis-B 
virus (HBV) carrier frequency 
among adults attending a primary 
care clinic in Jordan.
Methods: This study was per-
formed from January 2005 to April 
2006. Three hundred patients 
aged 35-55 years, female:male 
173:127 attending a primary care 
clinic were chosen randomly by 
simple random method and stud-
ied by detailed history, thorough 
physical examination, and serum 
HBs Ag was tested. Abdominal 
ultrasound, liver function tests 
and hepatitis profile were done 
for those with positive HBs Ag 
screening tests. Screening tests 
also were carried out on family 
members of those patients with 
positive tests.
Results: HBs Ag was positive in 
10 patients (3.3%) who came from 
a low socioeconomic class. Three 
of them (30%) had mild eleva-
tion of liver enzymes but all had 
normal abdominal ultrasound and 
negative tests for other types of 
hepatitis. HBs Ag was detected 
among 8 family members of 6 
infected patients. 
 
 
 
Conclusion: It is concluded that 
the HBV seropositivity rate (3.3%) 
among adults attending a primary 
care clinic is low in comparison to 
the average previously recorded 
rate (10%) in Jordan. Screening 
test is not necessary, but a  
hepatitis B vaccine program and 
health education should be  
considered.
Key words: Hepatitis B, Adults, 
Carrier, Primary care clinic
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Introduction 
Hepatitis B Virus (HBV) infection 
is an important cause of 
chronic hepatitis, cirrhosis, and 
hepatocellular carcinoma.
Although the reported rate of HBV 
has declined in the U.S.A by over 
50% since 1987 (1), “probably as a 
result of vaccination programmes, 
behavioral changes, refinements in 
blood screening procedures, and 
availability of virus inactivated blood 
components”, it remains high in the 
Western Pacific and South East 
Asia (2) .The prevalence of HBV 
carriage in the Middle East has been 
reported to vary from 5-18% (3, 4). 
In some regions, rates of less than 
5% have been reported (5, 6), while 
parts of Saudi Arabia and Egypt 
have rates as high as 28% and 20%, 
respectively. (7) 
The distribution of HBV in the Middle 
East is characterized by considerable 
variability in carrier rates, according 
to geographical areas and the 
community sampled (8, 9, 10). 
 
Patients and Method 
Three hundred patients who attended 
the primary care clinic at Marca 
Medical Center in Jordan were 
studied during the years January 
2005-April 2006 after obtaining 
their consent. They were chosen 
randomly through simple random 
method. A detailed history was taken 
from each including socioeconomic 
status, family members, personal 
history of jaundice, blood transfusion, 
injections, sexual contact, history of 
jaundice or hepatitis among family 
members, dental procedures and 
travel abroad. 
Complete and thorough examination 
was done for each patient and a 
sample of blood for hepatitis B 
surface antigen was sent to King 
Hussein Medical Center laboratory 
(both the haemoagglutination and the 
Elisa tests were used), liver function 
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tests, hepatitis profile (hepatitis A 
antibodies, hepatitis C antibodies, 
anti-HBe and HBe Ag). In addition an 
abdominal ultrasound was performed 
on these patients. A screening 
test for HBs Ag was carried out for 
each member of families of carrier 
patients. Family members who were 
negative were advised to take the 
hepatitis B vaccine as recommended. 
 
Results 
Most patients came from families 
of low socioeconomic class with 
an income of less than 300 JD 
monthly (the classification of the 
socioeconomic status in Jordan 
depends on an arbitrary base in 
which low class is defined as a 
family income of less than 350 JD 
per month). A history of jaundice 
was found in 7 patients and one of 
them had positive HBs Ag. A history 
of jaundice was observed in 13 
family members of the patients, two 
of them had neonatal jaundice and 
11 had clinical hepatitis. None of 
the patients received blood and a 
history of injections, or drug abuse 
was not divulged. Five patients had 
a history of dental procedures but 
none of them was a carrier of HBV. 
Ten patients were found to be HBs 
Ag positive. Only one of them had a 
history of jaundice and none of them 
had history of blood transfusion, 
surgery or sexual contact or history 
of hepatitis B vaccination in the last 
5 years. Three of them had mild 
elevation of liver enzymes as shown 
in Table 1 and the ten students had 
normal abdominal ultrasound and 
negative tests for other types of 
hepatitis.
Eight family members of those 
patients were HBs Ag positive, two of 
them were sons and six were wives. 
 
Discussion 
Previous studies in Jordan (9, 11) 
have shown that family size and 
particularly socioeconomic status 
have an important influence on 
the adult HBV carrier rate, with the 
highest rate (11%) being reported in 
the lower socioeconomic category, 
and the lowest rate (4%) in the higher 
category. 
 
Our results are consistent with 
those described in the literature. 
Most of our patients came from low 
class families and had large family 
members. The size of the patient’s 
family adversely affected the carrier 
rate as reported by Toukan et al 
(11). The ten patients with positive 
tests had an average of 10 family 
members. 
Prenatal transmission of HBV in the 
Middle East probably contributes 
only minimally to the HBV carrier 
population. In a combined study of 
four countries in the Middle East, 
only 21% of children born to HBs Ag 
positive mothers became infected. 
One factor accounting for this may 
be the low prevalence of hepatitis B 
e antigen (HBe Ag) positivity (13%) in 
HBs Ag positive mothers in the region 
(9). 
Interfamilial non-sexual, non-parental 
contact has been emphasized 
as an important means of virus 
transmission (11) and is the major 
route of infection among children 
in the Middle East. In our study the 
pattern of transmission could not be 
determined.
All seropositives were asymptomatic 
and potentially ineffective. However 
the number is small and a routine 
screening of these patients for 
HBs Ag is not mandatory but a 
vaccine program for those who 
are susceptible to HBV is to be 
considered. A vaccination program 
of newborns was started in 1995 in 
Jordan.
To clarify the current evidence of this 
study further studies are needed on 
larger populations and over longer 
periods.
Conclusion
The seropositivity of HBV among 
adults attending primary care clinic 
is low (3.3%) as compared to the 
4-11% carrier state previously 
recorded among the population in 
general in Jordan; screening test 
is not mandatory but vaccination 
programmes and health education 
are suggested. 
 
References 
1- Hollinger F B, “Comprehensive 
control (or elimination) of hepatitis B 
virus transmission 
in the United States “Gut 1996; 38 
(supp 2):S24-S30
2- I D Gust, “Epidemiology of 
hepatitis B infection in the Western 
Pacific and South East
Asia “Gut 1996; 36 (supp2):S18-S23
3- Shinoj P, Al-Kassab S, “Hepatitis B 
antigen in Iraq “Lancet 1973; ii: 1269
4- El-Guneid A M, Gunaid A A, O`Neil 
A M, Zuriekat N I, Coleman J C, 
Murray- Lyon IM, “Prevalence of 
hepatitis B, C and D virus markers 
in Yemeni patients with chronic liver 
diseases “J .Med Virol 1993 ;40:330-
3 
5- Al Kaderi S, Al-Nakib W , 
“Prevalence of HBs Ag and anti HBV 
in Kuwait “J Kuwait Med Assoc 1983 
;13:99-105
6- Nashef L,Thalgi A, “Hepatitis B 
serology among the Palestinian 
population “Ann Trop Paediatr 1992 
;12:321-5 
7- Toukan A, and the Middle East 
Regional Study group,”Strategy for 
virus infection in the Middle East and 
Africa “Vaccine 1990; 8:S117-S121.
8- Al-Faleh F Z, “Hepatitis B infection 
in Saudi Arabia “Ann Saudi Med 
1988; 8:474-80
9- Toukan A U, Sharaiha Gut 1996; 
38Z K, Abu-El-Rub O a, et al “The 
epidemiology of hepatitis B virus 
among family members in the 
Middle East “Am .J Epidemiol 1990; 
132:220-32 
 
Table 1: Liver function test 
MEDICINE AND SOCIET Y
MIDDLE EAST JOURNAL OF FAMILY MEDICINE  •  VOLUME 7 , ISSUE 10 
   
MIDDLE EAST JOURNAL OF FAMILY MEDICINE VOLUME 10 ISSUE 6
CME QUIZ
10- Al-Faleh F Z ,Ayoola E A ,Arif 
M , “Seroepidemiology of hepatitis 
B virus infection in Saudi Arabia 
children : a base line survey for mass 
vaccination against hepatitis B “J 
Infect 1992 ;24:197-206
11- Toukan A U, “Hepatitis B in the 
Middle East: aspects of epidemiology 
and liver disease after infection “Gut 
1996; 38 (supp2):S2-S4.
CME Quiz 
 
Ahmed, aged 3 months, presents with a 24 hour history of lethargy, general 
disinterest, anorexia, fever and cold skin.
On examination the child looks sick, 
inactive, with facial flushing and a fine macular rash on his trunk.
His vital signs are:
Respiratory rate 44/minute
Pulse 120/minute
BP 90/60
Temperature 39 C
There is no neck stiffness but the extremities feel cold 
 
 
 
Ahmed is observed in the emergency department for 4 hours after which 
time he became very lethargic and developed the rash similar to that in the 
photograph.
His vital signs were recorded as follows:
Temperature 39.5 C
Respiratory rate 48
Pulse 130
BP 85/50
In reference to Ahmed’s condition, which of the following statements do you 
consider to be correct/true?
 
A. The rash is haemorrhagic (purpura).
B. The probability diagnosis is staphylococcal septicaemia.
C. Blood should be taken for culture.
D. Intravenous benzylpenicillin should be administered.
E. Intravenous benzylpenicillin should be administered.
Source: Child health. Professor John Murtasgh 
Publishers: medi+WORLD International 2009
Answers are on page 47
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Abstract   
Background & objective: The aim 
of the present study was to iden-
tify the causes of stigma associ-
ated with psychiatric diseases and 
methods of its alleviation in Saudi 
Arabia.
Methods: Sixteen focus groups 
were conducted in half of the 
Primary Health Care (PHC) centers 
of Khobar. The average number 
of adult female PHC attendees 
participating in each session was 
six. Each session lasted between 
45-60 minutes. Each session was 
conducted by 3 female research-
ers. The moderator followed a 
semi-structured questionnaire for 
asking about reasons of stigma 
associated with psychiatric dis-
eases and how to overcome such 
a stigma. Ten sessions could be 
audio-recorded after taking the 
consent of participants. The rest 
were transcribed by the assistant 
moderator. Collected data was 
analyzed for repeated themes and 
some quotations were selected.
Results: Useful opinions were  
given, which might help in  
alleviation of stigma, like: Provid-
ing mental health services by PHC 
centers or general hospitals to 
avoid the embarrassment asso-
ciated with visiting psychiatric 
hospitals. Since many people seek 
“Sheikhs” for mental problems, 
Muslim clergymen may participate 
in health education campaigns for 
alleviation of stigma. Providing 
mental health consultation by a 
psychologist at school and  
involving the children and their 
families in solving the problem 
might help in increasing  
acceptability of psychiatric serv-
ices early in childhood. Providing 
a hot line for psychiatric  
consultation might reduce  
embarrassment. 
Conclusion: Reducing the stigma-
tization of mental illness contin-
ues to be an important goal for 
mental health professionals in our 
community.
Key words: stigmatization,  
psychiatry
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Introduction 
Erving Goffman defined stigma as 
the process by which normal identity 
is spoiled by the reactions of others 
[1]. Stigmatization of individuals 
with mental illnesses is widespread 
and serves as a major barrier to 
treatment [2].
The public generally holds negative 
stereotypes toward individuals with 
psychological problems, leading 
to potential discrimination toward 
these individuals. The internalization 
of these negative beliefs results in 
self-stigma, leading to reduced self-
esteem and motivation to seek help 
[3].
Research on psychological correlates 
of stigmatization of mental illness 
has shown that an important and 
surprising predictor of stigma is the 
greater belief in biological or genetic 
bases of mental illness [4]. Phelan 
theorized that genetic causes of 
mental illness are perceived as 
permanent, which raises discomfort 
because of the implication that 
complete recovery is impossible. 
Conversely then, optimism about the 
effectiveness of treatment might be 
expected to reduce stigma [5].
Stigma may be obvious and direct, 
such as someone making a negative 
remark about your mental health 
condition or your treatment. Or it 
can be subtle, such as someone 
assuming you could be violent or 
dangerous because you have a 
mental health condition. These and 
other forms of stigma can lead to 
feelings of anger, frustration, shame 
and low self-esteem, as well as 
discrimination at work, school and in 
other areas of life. For someone with 
a mental illness, the consequences 
of stigma can be devastating. Some 
of the harmful effects of stigma 
include: trying to pretend nothing is 
wrong, refusal to seek treatment, 
rejection by family and friends, work 
or school problems or discrimination, 
difficulty finding housing, being 
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subjected to physical violence or 
harassment or inadequate health 
insurance coverage of mental 
illnesses [6].
The focus group method is a 
technique of group interview that 
generates data through the opinions 
expressed by participants. Focus 
groups have become an increasingly 
popular method of data collection in 
health care research.
Since stigma associated with 
psychiatric diseases is a social 
related problem, focus group 
technique is thought to be the best 
methodology to understand the 
attitudes of the Saudi community. 
Our aim was to identify the causes 
of stigma associated with psychiatric 
diseases and methods of its 
alleviation in Khobar, Saudi Arabia. 
 
Methodology 
A qualitative research was 
conducted in four out of eight PHC 
centers in Khobar. Health centers 
with the largest population were 
selected. Sixteen focus groups 
were conducted during November 
2010. Adult female consumers, 
attending the health centers for any 
reason were invited to participate 
in the study. The average number 
participating in each session was 
six. Each session lasted between 
45-60 minutes. Each session 
was conducted by three female 
researchers.  
The moderator ran the session 
following a semi-structured 
questionnaire. She asked about 
the participant’s opinion about the 
magnitude of mental health problems 
in Saudi society, type of care the 
community seeks in case of mental 
health problems, the attitude towards 
seeking a psychiatric consultation, 
reasons of stigma associated with 
psychiatric diseases and how to 
overcome such stigma. She ensured 
that everyone had a chance to say 
what they wished to and that the 
group was not dominated by one 
individual. She also kept neutral 
during the whole session. 
One assistant moderator audio-
recorded or transcribed the session. 
The other assistant moderator 
was responsible for observing and 
reporting the non-verbal responses. 
Ten sessions could be audio-
recorded after taking the consent of 
participants and assuring them about 
the confidentiality of the gathered 
information, while transcripts were 
made for the rest. At the end of 
each session summary comments 
were verified with the participants to 
check if they really represented their 
opinions. Sessions were conducted 
until no new data emerged.
Collected data was analyzed 
for repeated themes and some 
quotations were selected. 
 
Results and Discussion 
It should be noted that this research 
is qualitative in nature. Its purpose 
is not to find how many people are 
engaged in a certain behavior or hold 
a certain opinion, but to identify the 
kinds of behavior and opinion that 
exist, and the possible reasons for 
this behavior.
Type of care the community seeks 
in case of mental health problems: 
- It was frequently mentioned that  
  some patients seek help of their  
  family or friends first and then may  
  consult the psychiatrist, as many  
  girls would turn to their mothers in  
  solving their problems.
- On the other hand, it was also  
  reported that many patients go  
  to “sheikhs” (religious people)  
  for treatment by Qur’an. However,  
  others think that most patients even 
   refuse to go to the sheikh.
   o It was stated that: “People who  
      have severe psychiatric problems 
      may even attempt suicide to be  
      relieved before seeking  
      psychiatric care”. 
- A minority of people seek medical  
  advice from a psychiatrist when  
  they have mental health problems.  
  However, they prefer to keep it  
  secret or consult psychiatrists away 
  from their community.
- Some participants stated that  
  acceptance of psychiatric  
  counseling differs by age (young  
  generations would accept it more  
  than the older generations) and  
  gender (females would accept it  
  more than males). 
The study conducted by Mann and 
Himelein about factors associated 
with stigmatization of persons with 
mental illness, reported similar 
findings as stigmatization among 
females was significantly less than 
among males [2]. 
 
Although the word “stigma” indicates 
something negative or shameful, 
stigma may also be useful. As David 
Shaffer has pointed out, “we need 
to destigmatize mental illness and 
its treatment … but we do not want 
to destigmatize suicide and suicide 
attempts.” The harmful effects 
resulting from destigmatization 
of suicidal behavior is that it may 
normalize it and make it appear 
more reasonable [7,8]. The only 
study conducted in Saudi Arabia 
for investigating the parasuicide 
phenomena reported a parasuicide 
rate of 20.7 per 100,000 in an Arab 
industrial community in the Eastern 
Province [9]. It is substantially lower 
than the reported rates in the West, 
which range between 3-5% [10]. 
The results of the study confirm that 
the act is predominantly the activity 
of young females, and disordered 
interpersonal relationships with 
spouses and parents stand out as 
precipitating factors. Acute reaction 
to stress was the commonest 
diagnosis followed by depression [9]. 
Accordingly, we believe that Islamic 
rules prohibiting suicidal behavior 
play an important positive role in 
stigmatization of suicidal attempts.
The systematic review conducted by 
Gulliver et al. in 2010 for perceived 
barriers and facilitators to mental 
health help-seeking revealed that 
only 35% of those surveyed with a 
common mental disorder sought help 
during the previous year. Analysis of 
qualitative studies revealed that the 
most frequently mentioned barrier 
was stigma, which was reported in 
over three-quarters of the studies. In 
addition, almost half of the studies 
cited issues related to confidentiality 
and trust. Over one-third of studies 
referred to concern about the 
characteristics of the provider and 
reliance on self as perceived barriers 
to help-seeking. Friends and family 
were often the preferred sources of 
help over health professionals. 
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The reported findings were similar to 
our findings [11].  
 
Reasons for stigma associated 
with psychiatric diseases in the 
Saudi community: 
- Traditions, cultural norms and  
  the way people were raised were  
  frequently mentioned as a main  
  reason:
  o One of the participants stated  
     “this is something we grow with,  
     as part of our culture, because in  
     the past psychiatric hospitals  
     were treating crazy people only”.
...o Another one said “if anyone goes  
     to these hospitals people will  
     directly consider him crazy”.
- About half of the participants  
  mentioned that people fear the  
  reactions of psychiatric patients;  
  they expect anger and violence.
- Many participants reported that  
  people think psychiatric diseases  
  can’t be cured.
- Many stated that psychiatric  
  diseases are hereditary.
...o “Families hide their psychiatric  
      patient. If the society would know  
      about the mentally ill family  
      member, girls of the family  
      wouldn’t marry”. 
- Lack of community awareness was  
  frequently mentioned:
  o One of the participants  
     mentioned: “People are not aware 
     that their soul can get sick as well  
     as their body”.
   o Another participant stated:  
     “The community doesn’t exactly  
       understand the role of  
       psychiatrist.”
- Some participants mentioned the  
  fear of side effects of psychiatric  
  medications.
- Less frequently mentioned was the  
  belief that the doctor is a stranger  
  and not trustworthy.
- The psychiatric medical record  
  might be used against the patient in 
  case of legal conflicts.
   o It was mentioned that: “In case  
      of marital conflicts the wife may  
      use the psychiatric medical  
      certificate for getting divorce.”
   o “It can be an excuse for multi- 
       marriage in case of female  
       patients.”
 
According to WHO, 64% of countries 
do not have any mental health 
legislation or have legislation that is 
more than 10 years old. Therefore, 
countries should adopt appropriate 
mental health policies, laws and 
services that promote the rights of 
people with mental disabilities and 
empower them to make choices 
about their lives, provide them with 
legal protections, and ensure their full 
integration and participation into the 
community. In Saudi Arabia, a mental 
health act is awaiting approval. 
The General Directorate for Mental 
Health has developed a manual 
of procedures and regulations for 
mental health institutions in the 
country until the mental health act 
is approved. Details about the year 
of enactment of the mental health 
legislation are not available [12].
The systematic review conducted 
by Gulliver et al. [11] revealed that 
top rated barriers from quantitative 
studies were; believing that no one 
could help [13], not liking to disclose 
personal matters to a stranger [14], 
and not feeling comfortable talking 
to a general practitioner whom the 
person did not know [15], which are 
similar to our findings.
Suggestions for alleviating the 
stigma:
- It was frequently reported that  
  providing mental health services 
  by primary health care centers or 
  general hospitals may encourage 
  people to seek psychiatric care.
   o One of the participants even  
      stated: “Change the name of  
      psychiatrist, give it a new name  
      more acceptable to the  
      community.”
It is worth mentioning that the 
Ministry of Health, according to 
recommendations of WHO, started 
implementing a mental health 
program through primary health care 
in the Eastern Province. Primary 
care physicians provide basic mental 
health services and selected primary 
care physicians, who have received 
additional training, serve as referral 
sources for complex cases. One of 
the eight health centers in Khobar is 
considered a referral center [16].
It was frequently suggested to 
raise public awareness: 
   o About the importance of early  
      detection and management  
      of psychiatric diseases for better  
      outcome.
   o And to emphasize that mental  
      health disorders have a biological 
      aspect and can be treated like  
      any other health condition.
- Providing a psychologist instead of  
  social worker at school, would help  
  in introducing the habit of seeking  
  psychological care since childhood.  
  It will also increase the acceptance 
  of children and parents to mental  
  health problems.
- Involving the family and friends  
  of the psychiatric patients in the  
  treatment process would increase  
  community acceptance.
- Providing a hot line for psychiatric  
  consultation would be highly  
  effective since the identity of the  
  patient will be totally unknown. 
 
Conclusion and 
Recommendations 
Our findings suggest that reducing 
the stigmatization of mental illness 
continues to be an important goal for 
mental health professionals in our 
community.
Many useful opinions were given 
during the focus group sessions, 
which might help in alleviating the 
stigma, like:
1- Providing mental health services  
    by primary health care centers  
    or general hospitals to avoid the  
    embarrassment associated with  
    visiting psychiatric hospitals.
2- Raising public awareness about  
    mental health problems and their  
    treatability.
3- Since many people seek “Sheikhs” 
    for mental problems. Muslim  
    clergymen may participate in  
    health education campaigns for  
    alleviation of stigma.
4- Providing mental health  
    consultation by a psychologist at  
    school and involving children and  
    their families in solving the  
    problem helps in increasing  
    acceptability of psychiatric  
    services early in childhood.
5- Providing a hot line for psychiatric  
    consultation service. 
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6- Future research should assess  
    stigma associated with a wider  
    variety of predictors and disorders. 
    The more precise researchers  
    can be, about variables associated 
    with stigma, the more effectively  
    we can pursue our ultimate goal:  
    the elimination of prejudice toward  
    individuals with mental illnesses.
7- Mental health legislation should be 
    encouraged. 
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Abstract   
Background: Asthma is a chronic 
condition which affects qual-
ity of life and is a major health 
problem in most regions of the 
world. Therefore, we assessed 
the impact of a computer learning 
program on asthmatic patients’ 
quality of life.
Methods: A quasi-experimental 
study was implemented. Patients 
with asthma were randomly as-
signed to intervention and control 
groups. The intervention of this 
study was a computer learn-
ing program aiming to improve 
asthma patients’ quality of life and 
was delivered to the intervention 
group. The control group received 
no training. Patients’ quality of 
life in physical, psychological, 
economic, and general health 
dimensions was assessed using 
the standard SF-36 questionnaire 
before, and three months after, 
intervention.
Results: Sixty patients were 
recruited to the study (interven-
tion: n=30; control: n=30). In the 
intervention group, quality of life 
was significantly improved in 
physical (P=0.003), psychologi-
cal (P=0.033), and general health 
(P=0.000) dimensions while 
comparing post-test to pre-test 
results; but there was no improve-
ments in the economic aspect 
(P=0.202). In the control group, 
no significant difference was 
revealed between pretest and post 
test results. 
Conclusions: Computer learning 
approach can be a useful method 
in promoting quality of life in pa-
tients suffering from asthma.
Keywords: Computer learning, 
Asthma, Quality of Life
Effect of computer learning on quality of life of Iranian 
asthmatic patients 
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Introduction 
Asthma is the most common chronic 
respiratory disease and a major 
health problem in most regions of 
the world (1, 2) with a prevalence of 
40% in some areas. The prevalence 
of asthma in Iran is 7.5% but this 
estimate is higher in urban areas 
especially metropolitan areas (3). 
Asthma symptoms can disturb a 
patients’ physical activity, quality of 
sleep, emotional functioning, and 
family life (4). These issues affect 
patients’ Quality Of Life (QOL). 
Asthma cannot be cured when it 
occurs(5), moreover it is a chronic 
condition; therefore, promoting QOL 
is of importance to asthma patients. 
As noted above, symptoms and 
signs are mainly responsible for 
destroying a patients’ quality of 
life; therefore, proper management 
of these problems could be 
considered as a solution in this 
regard (6). Several studies on 
asthma patients have reported the 
effect of educational intervention on 
symptom alleviation, anxiety control 
(7), QOL promotion (7, 8), and 
self care (9). Gaining the ability of 
participating in daily physical activity 
and reducing the number of medical 
encounters and hospitalization (10) 
are among other beneficial effects 
of educational interventions on 
asthma patients. However, little is 
known about the effectiveness of 
computer learning programs on 
QOL especially in asthma patients. 
Therefore, the aim of present study 
was to evaluate the effect of an 
educational program based on 
computer learning methods on QOL 
of asthma patients. 
 
Materials and Methods 
A quasi-experimental study was 
conducted. A convenience sampling 
method was implemented to recruit 
60 asthma patients from people 
who were referred to the lung clinics 
of Tehran University of Medical 
Sciences’ hospitals (Tehran, Iran, 
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May-December 2010). Participants 
were then randomly assigned to 
intervention (n=30) and control 
(n=30) groups. All participants should 
be asthmatic patients based on the 
physician’s diagnosis, while no other 
concomitant chronic disease such as 
cancer, diabetes, and psychological 
disorders should be present; subjects 
were also to be in an age range of 
18 to 65 years, be able to speak 
in Persian language, have basic 
reading/writing skills, and be able to 
work with the computer. Participants 
were excluded from the study if 
they experienced severe asthma 
attacks or other disorders which 
noticeably affected QOL; they were 
also excluded if they did not use 
the educational Compact Disc (CD) 
or the researcher could not contact 
them during follow-up time.
The intervention method was a 
CD which was delivered to the 
intervention group; the control group 
did not receive any education. 
Each patient in the intervention 
group received instructions on 
the application of the CD. The 
researchers prepared the CD and 
obtained its publication license 
from the Ministry of Culture and 
Islamic Guidance. Developing the 
CD, researchers first established 
the learning goal and identified the 
target population (asthma patients). 
The main educational goal was “to 
promote asthma patients’ knowledge 
about asthma and its management”. 
Achieving this goal, the educational 
content of the CD was developed in 
eight sub-titles, including: 
1) definition and classification of  
    asthma, 
2) Prevalence of asthma, 
3) Risk factors of the disease,
4) Signs and symptoms,
5) Exacerbating factors,
6) Medication in asthma and how  
    to use supplement instruments of 
    medication, 
7) ways to prevent and manage the  
    exacerbating factors, and 
8) how to prevent, control, manage  
    and treat asthma. 
The CD was designed in the form 
of multimedia software, in which 
patients could choose the written 
or the audiovisual format of the 
information. Furthermore, patients 
could double click on each sub-title to 
review it. Patients were followed for 
12 weeks. The researcher arranged 
3-4 phone calls during follow-up 
time to assure that all patients had 
used the CD and to answer patients’ 
queries. Data was collected before 
and 12 weeks after intervention in 
both groups.
The questionnaire of the present 
study consisted of three parts: 1) 
baseline characteristics, including 
age, sex, marital status, educational 
level, employment, dependency 
for care at home, and tobacco/
alcohol use; 2) disease related 
information, including duration of 
the disease, number of medical 
encounters and hospitalization, 
severity of the disease, types of 
medication, symptoms of asthma 
(e.g. cough, wheezing, sweating, 
etc.), sexual problems, and 
digestive complications; and 3) 
QOL questionnaire, including four 
dimensions: physical (13 questions), 
psychosocial (14 questions), socio-
economic (8 questions), and general 
health (four questions). One open-
ended question was included at the 
end of the questionnaire assessing 
patients’ satisfaction of and opinion 
about the educational CD.
Designing the QOL questionnaire, 
SF-36 and Asthma Quality Of Life 
Questionnaires (AQLQ) were used. 
Minor revisions in the content and 
face validity of the questionnaire 
were made by implementing the 
results of the consensus of 10 
experts’ opinions. Assessing the 
reliability of the QOL questionnaire, 
Cronbach’s alpha coefficient was 
used which was 62% in the physical 
dimension, 84% in the psychosocial 
dimension, and 79% and 68% in 
socio-economic and general health 
dimensions respectively.
Comparing both groups regarding 
demographic and health related 
statistics, Pearson chi-square and 
Fisher’s exact tests were used. 
Comparing both groups in terms of 
QOL, independent t-test was used. 
Paired t-test was implemented for 
the comparison of QOL before and 
after intervention in each group. 
Spearman’s correlation coefficient 
was used to assess the correlation 
between ordinal variables. Ethics 
committee of TUMS approved the 
research protocol. The aim of the 
study was demonstrated and written 
informed consent was obtained from 
all study participants. They were 
assured about the confidentiality 
of their information and free 
participation in the study. After 
finishing the post-test phase, the 
educational CD was delivered to the 
control group as well.
 
Results 
At baseline, both groups were 
homogenous regarding baseline 
characteristics, health related 
information, QOL (Table 1 - next 
page). 
 
Comparing pre-test/post-test results, 
no significant difference was shown 
in the QOL of the control group. In 
the intervention group, however, 
QOL was significantly improved in 
physical, psychological, and general 
health dimensions but was not 
improved in the economic aspect 
(Table 2 - page 51). 
 
In intervention vs. control group, 
there was a significant increase in 
mean scores of physical (P=0.002), 
psychological (P=0.001), and general 
health (P=0.000) dimensions in the 
post-test phase. However, the socio-
economic dimension did not improve 
significantly in this phase (P=0.061) 
(Table 3 - page 51). 
 
Twenty one (70%) participants were 
completely and nine patients (30%) 
were moderately satisfied with the 
educational method in this study. 
 
Discussion 
Educating patients has been 
identified as a cornerstone in 
management of asthma; however, 
there are still ambiguities about 
the benefits of different teaching 
techniques (11). The results showed 
that computer learning improved the 
quality of life of asthmatic patients in 
physical, psychosocial, and general 
health dimensions. Improvement in 
the physical dimension might be the 
result of improvement in the 
MIDDLE EAST JOURNAL OF FAMILY MEDICINE  •  VOLUME 7 , ISSUE 100 MIDDLE EAST JOURNAL OF FAMILY MEDICINE VOLUME 10 IS UE 6
OFFICE BASED FAMILY MEDICINE
* Pearson chi square, ** 
Fisher Exact Test 
Table 1: Frequency 
distribution of the baseline 
and health related 
characteristics of study 
participants 
 
(Continued top of next page)
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°Paired t-test 
Table 2. Comparison of the QOL between pre-test and post-test phases in control and intervention groups
 
 
°Independent t-test 
Table 3. Comparison of the QOL in post-test phases between control and intervention groups
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the patients’ perception of their ability 
to perform daily living activities. 
This is one of the perceptions which 
we tried to induct to the learners 
in our educational intervention. 
Bakhshandeh et al. (2004) concluded 
that breathing training facilitates daily 
living activities of asthmatic patients 
by enhancing their physical capacity 
which itself promotes their QOL (12). 
Results also showed that our 
intervention improved the 
psychological dimension of QOL. 
Since participants obtained 
knowledge about the disease’s 
nature and management, their self-
esteem and sense of independency 
might be enhanced which itself can 
help them to “feel better”. Molassiotis 
(1997) noted that feeling of self-
control, self-assurance, and having a 
positive attitude toward the disease 
are important elements that affect 
patients’ quality of life (13).
Results showed significant 
improvement in the general health 
dimension of patients in intervention 
group. Mezarous (2003) stated that 
educating patients with asthma 
helps a 40% improvement in scores 
of QOL in all dimensions (14). 
Moudgila et al (2000) reported the 
effect of education on improving 
all dimensions of QOL (15). In the 
research by Krishna et al. (2003), 
some information was delivered 
to the control group while in the 
intervention group, information was 
delivered through a multimedia 
animation CD as well as face to face 
education. The results indicated that 
the method of education applied 
for the intervention group led to an 
increase in knowledge about asthma 
and reduction of the number of 
emergency visits by physicians (16).
There was no significant correlation 
between QOL and demographic 
characteristics. Similarly, Naeemi 
et al (2007) found no significant 
correlation between demographic 
variables and QOL and anxiety (7). 
Only a significant direct association 
was found between educational level 
and QOL in which the increase in 
educational level led to an increase 
in QOL. Therefore, promoting 
educational levels, knowledge and 
information might help improve the 
QOL in these patients. 
 
Conclusion 
Findings showed that the quality of 
life in asthmatic patients receiving 
computer learning can promote 
their quality of life in physical, 
psychological and general health 
domains but has no effect on the 
socio-economic aspect. Therefore, 
the research hypothesis “computer 
learning improves the quality of life 
of asthmatic patients” is accepted. 
These findings emphasize the 
necessity of effective education in 
managing asthma and improving 
quality of life in asthma patients. 
Further investigations are 
recommended for assessing the 
effect of computer learning on other 
aspects of asthma patients and on 
other chronic diseases.
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